Donald R. Coustan CV Last updated 17 Nov18

CURRICULUM VITAE

Name: Donald Ross Coustan, MD Born: Chicago, Illinois - October 18, 1943 Wife: Terri Distenfield Coustan Children: Rebecca, Rachel, David Home Address: 265 Seaside Drive Jamestown, RI 02835 401-423-2277

Business Address: Women & Infants Hospital of Rhode Island Maternal-Fetal Medicine Division 101 Dudley Street Providence, RI 02905-2401 401-274-1100, Extension 47452

Education and Training: Yale College, B.A. in Psychology (Magna Cum Laude), 1964. Yale Medical School, M.D., 1968 Internship: Straight Internal Medicine, Yale-New Haven Medical Center, 1968-1969 Residency: Obstetrics and Gynecology, Yale-New Haven Medical Center, 1969-1973

Professional Experience: Instructor in Obstetrics and Gynecology, Yale University School of Medicine, 1972-1973 Lieutenant Commander, Chief of Obstetrics, Naval Regional Medical Center, Oakland California, 1973-1975 Assistant Professor of Obstetrics and Gynecology, Yale University School of Medicine, 1975-1980 Director, Diabetes in Pregnancy Program, Yale University School of Medicine, 1975-1982 Attending Perinatologist, High Risk Pregnancy Program, Yale-New Haven Medical Center, 1975-19 Associate Professor of Obstetrics and Gynecology, Yale University School of Medicine, 1980-1982 Associate Professor of Obstetrics and Gynecology, Brown University Program in Medicine, 1982-1986 Director, Division of Maternal-Fetal Medicine, Women & Infants Hospital of Rhode Island, 1982-1991 Professor of Obstetrics and Gynecology, Brown University Program in Medicine, 1986-2018 Professor Emeritus of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, 2018- Director of Obstetrics, Women & Infants Hospital of Rhode Island, 1986-1991 Associate Chief of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, 1988-1991 Chairman, Department of Obstetrics and Gynecology, Brown University Program in Medicine, 1991-2008 Obstetrician and Gynecologist-in-Chief, Women & Infants Hospital of Rhode Island, 1991-2008 Surgeon-in-Chief, Obstetrics and Gynecology, Rhode Island Hospital, 1991-2008 Obstetrics & Gynecology Residency Program Director, 1991-2008 Chace/Joukowsky Professor and Chair of Obstetrics and Gynecology, Brown University School of Medicine, 1999- 2008 Women & Infants Hospital of RI, Designated Institutional Official for ACGME, 2007-2010 Interim Director, Division of Maternal-Fetal Medicine, Warren Alpert Medical School of Brown University and Women & Infants Hospital of RI, 2008-2009

Page 1

Attending Physician, Division of Maternal-Fetal Medicine, Warren Alpert Medical School of Brown University and Women & Infants Hospital of RI, 2009-2018

Last updated 23 May 18 2 Donald R. Coustan CV

Membership in Professional Organizations: HONORARY: Phi Beta Kappa, 1964 Sigma Xi, 1964 Honorary Member, Diabetic Pregnancy Study Group of the European Association for the Study of Diabetes, 1996-

LOCAL: New Haven Obstetrical Society, 1975-1982 Professional Advisory Board, March of Dimes, New Haven Chapter, 1980-1982 Professional Advisory Board, March of Dimes, Rhode Island Chapter, 1986-1991 Diabetes and Endocrine Society of Rhode Island, 1982-2000 Providence Medical Association, 1984- Executive Committee, 1986-1995

STATE: American Diabetes Association, Connecticut Affiliate, Board of Directors, 1980-1982 American Diabetes Association, Rhode Island Affiliate, Board of Directors, 1984-1993 Honorary Trustee, 1993-1995 Vice President, 1986-1991 Chairman, Professional Education Committee, 1985-1987 Rhode Island State Medical Society, 1983- President, 1989-1990 Secretary, 1988-1989 Peer Review Committee on Physician Competence, 1986-1994 AIDS Advisory Committee, 1987-1988 State of Rhode Island, Children's Code Commission, Subcommittee on Drug Exposed Children, 1989 State of Rhode Island, Department of Health Diabetes Professional Advisory Council, 1989-1994 HIV Program Advisory Committee, 1989-1991 Chair, HIV Provider Education Committee, 1995-1997

REGIONAL: New England Perinatal Society, 1982-2008 Program Chairman, 1987-1990 Obstetrical Society of Boston, 1985- Associate, 1985-1991 Fellow, 1991- Prudential Committee, 1994-96 Second Vice President, 1996-97 First Vice President, 1997-98 President, 1998-99 American College of Obstetricians and Gynecologists District I Meeting Scientific Program Chair, Newport, RI, October 1995 Advisory Board, Maine Diabetes in Pregnancy Project, 1986-1994 American Diabetes Association, New England Region Board of Directors, 1998-2002 President, New England Region, 2001-2002

Page 3 Donald R. Coustan CV NATIONAL: Fellow, American College of Obstetricians and Gynecologists, 1974- Committee on Technical Bulletins: Obstetrics, 1990-1993 Chair, 1993-1995 Precis Advisory Committee, 1999-2010 Chair, 2007-2010 American Diabetes Association, 1977- Council on Diabetes in Pregnancy Secretary, 1985-1986 Program Chairman, 1989-1991 Member, Task Force on Type I Diabetes in Pregnancy, 1986-1988 Member, Task Force on Gestational Diabetes, 1987-1989 Vice Chair, 1992-1994 Chairperson, 1994-1996 Professional Section Advisory Panel, 1994-1996 Vice Chair, 1995-1996 Chairperson, 1996-1997 Co-Chair, Task Force on the Professional Section, 1995-1997 Member, Future Directions Steering Committee, 1996-1997 Member, Marketing & Communications Committee, 1998-1999 Member, Publications Policy Committee, 1999-2001 Member, Programs Committee, 2001-2003 Member, Task Force on Building and Supporting Effective Volunteer Community Organizations, 2002-2003 Board of Directors, 2000-2003 Nominating Committee, 2003-2005 Steering Committee and Writing Group, 5th International Workshop-Conference on GDM, 2005 Professional Practice Committee, 2016-2018 Society of Perinatal Obstetricians (now Society for Maternal-Fetal Medicine), 1979- Leader, Special Interest Group on Diabetes, 1987-1989 Board of Directors, 1989-1992 Chairperson, Standards Committee, 1989-1991 Assistant Secretary/Treasurer, 1991-1993 Secretary/Treasurer, 1993-1995 Vice President/President Elect 1995-1996 President, 1996-1997 Lifetime Achievement Award, 2002 American Fertility Society, 1977-1981 American Medical Association, 1983- Diabetes CME Advisory Board, 1999-2001 Association of Professors of Gynecology and Obstetrics, 1982- APGO/Wyeth Leadership Development Program Advisory Committee, 1997-2000 Nominating Committee, 2005-2006 National Diabetes Advisory Council, Diabetes Treatment Centers of America Foundation, 1989-1990 National Perinatal Information Center Board of Directors, 1988-1991 Perinatal Research Society, 1989- Society for Gynecologic Investigation, 1989- Council of University Chairs of Obstetrics and Gynecology, 1991- American Gynecological and Obstetrical Society, 1993-2017. Life Fellow 2018- Fellowship Committee, 1999-2001 Representative to CREOG Council, 2000-2002 Treasurer, 2008-2012 President-elect, 2012-2013 President, 2013-2014 Page 4

Diabetes in Pregnancy Study Group, West, 1995 American Board of Obstetrics and Gynecology Associate Examiner, 1995-1997 Examiner, 1997-2008 Council on Resident Education in Obstetrics and Gynecology, Member, 2000-2003 Robert Wood Johnson Clinical Scholars Program, National Advisory Committee, 2001-2008 American Gynecological Club, 1997- Secretary/Treasurer, 2001-2004 President Elect, 2004-2005 President, 2005-2006

Board Certification: American Board of Obstetrics and Gynecology, 1976 (ABOG #8512) Voluntarily recertified, 1993, 1999 and annually thereafter Subspecialty Certification in Maternal-Fetal Medicine, 1979 (ABOG #8512), Voluntarily recertified annually since 2000

Licensure: National Board of Medical Examiners, 1969 Rhode Island State License (6028), 1982-2018 Massachusetts State License (213056), 2002-2016

Hospital Appointments: Attending Physician, Yale-New Haven Medical Center, 1975-1982 Consulting Staff, Griffin Hospital (Derby, Conn.), 1977-1982 Consulting Staff, Bridgeport Hospital (Bridgeport, Conn.), 1980-1982 Consulting Staff, Waterbury Hospital (Waterbury, Conn.), 1975-1982 Attending Physician, Women & Infants Hospital of Rhode Island, 1982-2018 Assistant Attending, Rhode Island Hospital, 1983-1991 Attending Physician, Rhode Island Hospital, 1991-2010 Consulting Staff, The Miriam Hospital, 1988-2010

University Committees: Director of Residency Selection, Yale Department of Obstetrics and Gynecology, 1975-1979 Admissions Committee, Yale Medical School, 1975-1979 Medical Library Task Force, Brown University, 1982-1985 Admissions Committee, Brown University Program in Medicine, 1983-1986 Graduate Medical Education Committee, Brown University Program in Medicine, 1983-1991 Health Services Advisory Committee, Brown University, 1983-1989 Committee on Academic Standing, Brown University Program in Medicine, 1985-1991 Postgraduate Referral Committee, Brown University Program in Medicine, 1986-1991 Residency Selection Committee, Department of Obstetrics and Gynecology, Brown University Program in Medicine, 1982- Chairman, 1986-1987, 1991-2008 Medical Council, Brown University, 1988-1991 Council of Clinical Chairs, 1991-2008

Last updated 23 May 18 5

Biomedical Faculty Council, 1992-2008 Major Search Committees: Chair of Medicine, 1997-1998 Chair of Surgery, 2000-2002 (Chair of Search Committee, 2001-2002) Chair of Pediatrics, 2002-2003

Hospital Committees Obstetrical Review Committee, Women & Infants Hospital, 1982-1986 Perinatal Mortality Subcommittee, Women & Infants Hospital, 1982-2008 Medical Education Committee, Women & Infants Hospital, 1983-2008 Chair, Departmental Executive Committee, Ob/Gyn, 1982- Pharmacy and Therapeutics Committee, 1982-1991 Residency Review Committee, 1983- Medical Staff Executive Committee, 1991-2008 Women & Infants Hospital Board of Trustees, 1991-2008 Finance Committee, 1991-2008 Planning Committee, 1991-2008 WIH/RIH Trustee Affiliation Committee, 1991-2008 Joint Conference Committee, 1991-2008 Patient Care Evaluation Committee, 1991-2008 Women & Infants Corporation Board of Directors, 1992-2008 Finance Committee, 1992-2008 Planning Committee, 1992-2008 Care New England Board of Trustees, 1996-12008

Medical School Courses Taught Lecturer, Second Year Pathophysiology Course, Yale Medical School, 1976-1982 Lecturer, Integrated Medical Sciences 374, Human Reproduction, Growth & Development, Brown University Program in Medicine, 1983-1986 Course Co-leader, Human Reproduction Section of Biomed 282, Brown University Program in Medicine, 1987-1995 Case presentation discussion group leader, Core Clerkship in Obstetrics & Gynecology, Brown University Program in Medicine, 1983-2018 Course Leader, Biomed 339B, elective in Maternal-Fetal Medicine, Brown University Program in Medicine, 1983-1991

Teaching Awards Women & Infants Hospital/Brown University Teaching Excellence Pin (Residents and Medical Students), 1992 and annually thereafter through 2017 Dean’s Teaching Excellence Award, 2002 Council on Resident Education in Obstetrics and Gynecology National Teaching Excellence Award, 2010. Outstanding Faculty Mentor 2010, Brown University/Women & Infants Hospital National Center of Excellence in Women’s Health.

Last updated 23 May 18 6

APGO (Association of Professors of Gynecology and Obstetrics) Excellence in Teaching Award, 2017

Grant Support Collaborative Population-Based Study of Gestational Diabetes Centers for Disease Control Principal Investigator: Donald R. Coustan Annual Total Costs: $83,000 (Total $249,000) Period of Support: 1984-1987

"Diabetes in Pregnancy: Effects on the Offspring" NICHD P50HD11343 Principal Investigator: W. Oh Subgrant 3: "Adaptation to Exercise in Pregnancy" Principal Investigator: Donald R. Coustan Percent effort: 15% Annual direct cost: $167,265 Period of Support: 1 Dec 85 - 30 Nov 90

"Risk Profile for Women With Gestational Diabetes Who Develop Overt Diabetes" Centers for Disease Control Principal Investigator: Donald R. Coustan Percent Effort: 10% Total cost: $398,223 Period of Support: 1 Oct 88 - 30 Sept 90

“Hyperglycemia and Adverse Pregnancy Outcomes” NICHD 1R01 HD34243-01A2 Principal Investigator: Boyd Metzger, MD (Northwestern University) Regional Director for North America: Donald R. Coustan, MD Total Cost: first year $866,000 Period of Support: 4 May 99 - 31 March 2004

“Building Interdisciplinary Research Careers in Women’s Health” NIH 1K12 HD043447-01 Principal Investigator: Donald R. Coustan, MD Total Cost: $2,498,224 Period of Support: 1 Oct 02 - 30 Sept 07

“Women’s Reproductive Health Research Career Development Center” NIH 1K12 HD50108-01 Principal Investigator: Donald R. Coustan, MD (5% effort), 2005-2008 Total Cost: $1,999,604 Period of Support: 30 Sep 05 – 31 March 2010

Last updated 23 May 18 7 Donald R. Coustan CV Editorial Reviewer: 1. American Journal of Obstetrics and Gynecology 2. Obstetrics and Gynecology 3. Diabetes Care 4. American Journal of Perinatology 5. New England Journal of Medicine 6. International Journal of Gynecology and Obstetrics 7. Proceedings of the Society for Experimental Biology and Medicine 8. Practical Diabetology 9. Journal of Clinical Endocrinology and Metabolism 10. Journal of Clinical Investigation 11. Diabetes 12. Clinical Chemistry 13. Diabetes, Nutrition and Metabolism 14. Journal of the American Medical Association 15. American Journal of Physiology: Endocrinology and Metabolism 16. Clinical Science 17. Endocrine Journal 18. Diabetologia 19. Life Sciences 20. Journal of Pediatrics 21. European Journal of Endocrinology 22. Diabetic Medicine 23. European Journal of Obstetrics and Gynaecology and Reproductive Biology 24. Pediatrics 25. Fertility and Sterility 26. Journal of the Society for Gynecological Investigation 27. Southern Medical Journal 28. Journal of Perinatology 29. Journal of Reproductive Medicine 30. American Journal of Epidemiology 31. Diabetes Research and Clinical Practice 32. Journal of Obstetrics and Gynaecology Research 33. British Journal of Obstetrics and Gynecology 34. Paediatric and Perinatal Epidemiology 35. Cochrane Reviews 36. Maternal and Child Health Journal 37. Drug Safety 38. Acta Obstetricia et Gynecologica Scandinavica 39. Expert Opinion on Drug Metabolism and Toxicology

Editorial Board Member: 1. Current Obstetric Medicine (Associate Editor, 1989-1995) 2. The Journal of Maternal-Fetal Medicine (1990-2001) 3. International Diabetes Monitor (1989-) 4. American Journal of Obstetrics and Gynecology (Advisory committee on policy) 1990-1992 1993-1997 5. Obstetrics and Gynecology (1991-1995) 6. Diabetes Spectrum (1991) 7. Diabetes Care Associate Editor, 1992-1996 Ad Hoc Editor, Proceedings of the Fourth International Workshop-Conference on Gestational Diabetes, 1997 Page 8

8. Diabetes (Ad hoc editorial board, proceedings of Third International Workshop-Conference on Gestational Diabetes, 1991) 9. Journal of the Society for Gynecologic Investigation (1993-2006) 10. Reproductive Sciences (2006-2010) 11. Journal of Maternal-Fetal and Neonatal Medicine (2002-2009)

Grant Reviewer 1. March of Dimes Birth Defects Foundation Regular reviews Ad hoc committee member for Basil O’Connor Starter Grant Reviews 2. Health Research Council of New Zealand 3. British Diabetic Association 4. Kaiser Foundation Research Institute 5. Lottery Grants Health Research Committee of the New Zealand Lottery Grants Board 6. NIH 7. Consultant, Congressionally Directed Diabetes Research Working Group at NIH, 1998 8. Diabetes UK 9. Irish Health Research Board Interdisciplinary Capacity Enhancement (ICE) Awards 2011

Publications in peer-reviewed journals:

1. Kling A, Coustan D: Electrical stimulation of the amygdala and hypothalamus in the kitten. Experimental Neurology 10:81, 1964. 2. Gault FP and Coustan DR: Nasal air flow and rhinencephalic activity. Electroencephalography and Clinical Neurophysiology 18:617, 1968. 3. Coustan DR, Rainey EC, Joseph TJ: Ovarian pregnancies with Dalkon Shield in situ; laparoscopic visualization. Southern Medical Journal 69:1456, 1976. 4. Lewis SB, Murray WK, Wallin JD, Coustan DR, Daane TA, Tredway DR, Navins JP: Improved glucose control in non-hospitalized pregnant diabetic patients. Obstetrics and Gynecology 48:260, 1976. 5. Lewis SB, Wallin JD, Kuzuya H, Murray WK, Coustan DR, Daane TA, Rubenstein AH: Circadian variation of serum glucose, C-peptide immunoreactivity and free insulin in normal and insulin-treated diabetic pregnant subjects. Diabetologia 12:343, 1976. 6. Coustan DR, Lewis SB: Insulin therapy for gestational diabetes. Obstetrics and Gynecology 51:306, 1978. 7. Coustan DR, Berkowitz RL Hobbins JC: Tight metabolic control of overt diabetes in pregnancy. American Journal of Medicine 68:845, 1980. 8. Gertner JM, Glasman MS, Coustan DR, Goodman DBP: Feto-maternal vitamin D relationships at term. Pediatrics 97:637, 1980. 9. Rudolf MCJ, Coustan DR, Sherwin RS, Bates SE, Felig P, Genel M: Efficacy of the insulin pump in the home treatment of pregnant diabetics. Diabetes 30:891, 1981. 10. Carpenter MW, Coustan DR: Criteria for screening tests of gestational diabetes. American Journal of Obstetrics and Gynecology 144:768, 1982. 11. Romero R, Chervenak FA, Coustan DR, Berkowitz RL, Hobbins JC: Antenatal sonographic diagnosis of umbilical cord laceration. American Journal of Obstetrics and Gynecology 143:719, 1982. 12. Coustan DR, Imarah J: Prophylactic insulin treatment of gestational diabetes reduces the incidence of macrosomia, operative delivery, and birth trauma. American Journal of Obstetrics and Gynecology 150:836- 843, 1984.

Last updated 23 May 18 9

13. Widness JA, Teramo KA, Clemons GK, Coustan DR, Cavalieri RL, Oh W, Welch GP, Schwartz R: Correlation of the interpretation of fetal heart rate records with cord plasma erythropoietin levels. British Journal of Obstetrics and Gynaecology 92:326, 1985. 14. Bellucci MJ, Coustan DR, Plotz RD: Cervical scleroderma: a case of soft tissue dystocia. American Journal of Obstetrics and Gynecology 150:891-892, 1984. 15. Widness JA, Cowett RM, Coustan DR, Carpenter MW, and Oh W: Neonatal morbidities in infants of mothers with glucose intolerance in pregnancy. Diabetes 34 (Suppl. 2): 61-65, 1985. 16. O'Brien, JA, Coustan DR, Singer DB, and Taylor MW: Prepartum diagnosis of traumatic fetal-maternal hemorrhage. American Journal of Perinatology, 2:214-216, 1985. 17. Reece EA, Egan JFX, Coustan DR, Tamborlane W, Bates SE, O'Neill TM and Fitzpatrick JG: Coronary artery disease in diabetic pregnancies. American Journal of Obstetrics and Gynecology 154: 150-151, 1986. 18. Kramer PD, Coustan DR, Krzeminski J, Broudy D, and Martin C: Hospitalization on the high risk maternity unit. General Hospital Psychiatry, 8:33-39, 1986. 19. Gertner JM, Coustan DR, Kliger AS, Mallette LE, Ravin N and Broadus AE. Pregnancy is a state of physiologic absorptive hypercalcuria. American Journal of Medicine, 81:451-456, 1986. 20. Coustan DR, Reece EA, Sherwin RS, Rudolf MCJ, Bates SE, Sockin SM, Holford T, and Tamborlane WV. : A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. Journal of the American Medical Association, 255:631-636, 1986. 21. Cowett RM, Coustan DR, and Oh W: Effects of maternal transport on admission patterns in a tertiary care center. American Journal of Obstetrics and Gynecology, 154:1098-1100, 1986. 22. Coustan DR, Widness JA, Carpenter MW, Rotondo L, Pratt DC and Oh W: Should the 50 gm, one hour screening test for gestational diabetes be administered in the fasting or fed state? American Journal of Obstetrics and Gynecology, 154:1031-1035, 1986. 23. Coustan DR, Widness JA, Carpenter MW, Rotondo L, and Pratt DC: The "Breakfast Tolerance Test:" Screening for gestational diabetes using a standardized mixed nutrient meal. American Journal of Obstetrics and Gynecology, 157:1113-1117, 1987. 24. Carpenter MW, Sady SP, Hoegsberg B, Sady MA, Haydon B, Cullinane EM, Coustan DR, and Thompson PD: Fetal heart rate response to maternal exertion. Journal of the American Medical Association 259:3006-3009, 1988. 25. Reece EA, Coustan DR, Hayslett JP, Holford T, Coulehan J, O'Connor TZ, and Hobbins JC: Diabetic nephropathy: pregnancy performance and fetomaternal outcome. American Journal of Obstetrics and Gynecology, 159:56-66, 1988. 26. Sady SP, Carpenter MW, Sady MA, Haydon B, Hoegsberg B, Cullinane EM, Thompson PD and Coustan DR: Prediction of VO2 max during cycle exercise in pregnant women. Journal of Applied Physiology 65:657-661, 1988. 27. Carpenter MW, Coustan DR, Widness JA, Gruppuso PA, Malone M, Rotondo LM: Postpartum testing for antecedent gestational diabetes. American Journal of Obstetrics and Gynecology 159:1128-1131, 1988. 28. Coustan DR: Pregnancy in diabetic women (editorial). New England Journal of Medicine. 319:1663-1665, 1988. 29. Young SB, Martelly PD, Greb L, Considine G and Coustan DR: The effect of intraumbilical oxytocin on the third stage of labor. Obstetrics and Gynecology 71:736-738, 1988. 30. Sady SP, Carpenter MW, Thompson PD, Sady MA, Haydon B, Coustan DR: Cardiovascular response to cycle exercise during and after pregnancy. Journal of Applied Physiology 66:336-341, 1989. Last updated 23 May 18 10

31. Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA: Maternal age and screening for gestational diabetes: a population-based study. Obstetrics and Gynecology 73:557-561, 1989. 32. Spirito A, Williams C, Ruggiero L, Bond A, McGarvey ST, Coustan D: Psychological impact of the diagnosis of gestational diabetes. Obstetrics and Gynecology 73:562-566, 1989. 33. Carr S, Coustan DR, Martelly P, Brosco F, Rotondo L: Precision of reflectance meters in screening for gestational diabetes. Obstetrics and Gynecology 73:727-731, 1989. 34. Ruggiero L, Spirito A, Bond A, Coustan D, McGarvey S: Impact of social support and stress on compliance in women with gestational diabetes. Diabetes Care 13:441-443, 1990. 35. Carpenter MW, Sady SP, Sady MA, Haydon B, Coustan DR, Thompson PD: Effect of maternal weight gain during pregnancy on exercise performance. Journal of Applied Physiology 68:1173-1176, 1990. 36. Spirito A, Ruggiero L, Bond A, Rotondo L, Coustan DR: A screening measure to assess knowledge of diabetes in pregnancy. Diabetes Care 13:712-718, 1990. 37. Sady MA, Haydon BB, Sady SP, Carpenter MW, Thompson PD, Coustan DR: Cardio-vascular response to maximal cycle exercise during pregnancy and at two and seven months postpartum. American Journal of Obstetrics and Gynecology 162:1181-1184, 1990. 38. Spirito A, Ruggiero L, McGarvey ST, Coustan DR, Low KG: Maternal and Fetal Health Locus of Control During Pregnancy: A Comparison of Women With Diabetes and Nondiabetic Women. Journal of Reproductive and Infant Psychology 8:195-206, 1990. 39. Spirito A, Ruggiero L, Bowen A, McGarvey S, Bond A, Coustan DR: Stress, Coping and Social Support as Mediators of the Emotional Status of Women With Gestational Diabetes. Psychology and Health 5:111-120, 1991. 40. Carr SR, Aronson MP, Coustan DR: Survival rates of monoamniotic twins do not decrease after 30 weeks' gestation. American Journal of Obstetrics and Gynecology 163:719-722, 1990. 41. Ojomo EO and Coustan DR: Absence of evidence of pulmonary maturity at amniocentesis in term infants of diabetic mothers. American Journal of Obstetrics and Gynecology 163: 954-957, 1990. 42. Neiger R, Contag SA, Coustan DR: The resolution of preeclampsia-related thrombocytopenia. Obstetrics and Gynecology 77:692-695, 1991. 43. Reece EA, Coustan DR, Sherwin RS, Tuck S, Bates S, O’Connor T, Tamborlane WV: Does intensive glycemic control in diabetic pregnancies result in normalization of other metabolic fuels? American Journal of Obstetrics and Gynecology 165:126-130, 1991. 44. Neiger R, Coustan DR: The role of repeat glucose tolerance tests in the diagnosis of gestational diabetes. American Journal of Obstetrics and Gynecology 165:787-790, 1991. 45. Neiger R, Coustan DR: Are the current ACOG glucose tolerance test criteria sensitive enough? Obstetrics and Gynecology 78:1117-1120, 1991. 46. Cousins L, Baxi L, Chez R, Coustan D, Gabbe S, Harris J, Landon M, Sacks D, Singh S. Screening recommendations for gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 1991; 165: 493-496. 47. Coustan DR: Diagnosis of gestational diabetes: what are our objectives? Diabetes 40 (Suppl 2):14-17, 1991. 48. Elixhauser A, Wechsler JM, Kitzmiller JL, Bennert HW, Coustan DR, Gabbe SG, Herman W, Kaufmann RC, Ogata ES, Marks JS, Sepe SJ: Financial implications of implementing standards of care for diabetes and pregnancy. Diabetes Care 15 (Suppl 1):22-28, 1992. 49. Spirito A, Ruggiero L, Coustan D, McGarvey S, Bond A: Mood state of women with diabetes during pregnancy. Journal of Reproductive and Infant Psychology 10:29-38, 1992. Last updated 23 May 18 11

50. Coustan DR: Gestational diabetes: State of the union. Editorial in Diabetes Care 15:716-717, 1992. 51. Neiger R, Contag SA, Coustan DR: Preeclampsia effect on platelet count. American Journal of Perinatology 9:378-380, 1992. 52. Hoegsberg B, Gruppuso PA, Coustan DR: Hyperinsulinemia in macrosomic infants of nondiabetic mothers. Diabetes Care 16:32-36, 1993. 53. Coustan DR, Carpenter MW, O’Sullivan PS, Carr SR: Gestational diabetes: predictors of subsequent disordered glucose metabolism. American Journal of Obstetrics and Gynecology 168:1139-1144, 1993. 54. Elixhauser A, Wechsler JM, Kitzmiller JL, Marks JS, Bennert HW Jr, Coustan DR, Gabbe SG, Herman WH, Kaufmann RC, Ogata ES, Sepe SJ: Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 16: 1146-1157, 1993. 55. Ruggiero L, Spirito A, Coustan D, McGarvey S, Low KG: Self-reported compliance with diabetes self- management during pregnancy. International Journal of Psychiatry in Medicine 23:195-207, 1993. 56. Coustan DR: Gestational diabetes. Diabetes Care 16 (Suppl 3):8-15, 1993. 57. Coustan DR: Editorial: Management of gestational diabetes mellitus: a self-fulfilling prophecy? J.A.M.A. 275:1199-1200, 1996. 58. Star J, Canick JA, Palomaki GE, Carpenter MW, Saller DN, Sung CJ, Tumber MB, Coustan DR: The relationship between second-trimester amniotic fluid insulin and glucose levels and subsequent gestational diabetes. Prenatal Diagnosis 17:149-154, 1997. 59. Coustan DR: Invited commentary: Gestational diabetes: a continuum of risk. European Journal of Endocrinology 137:13-14, 1997. 60. Coustan DR: Editorial: Pre-conception planning: the relationship’s the thing. Diabetes Care 21:887-888. 1998. 61. Kuhl C, Coustan D, Kitzmiller J, Philipps A, Binder C, Schneider H: Report on the 28th annual meeting of the Diabetic Pregnancy Study Group. Diabetologia 41(Suppl):8-14, 1998. 62. Coustan DR, Carpenter MW: The diagnosis of gestational diabetes. Diabetes Care 21(Suppl 2): B5-B8, 1998. 63. Metzger BE, Coustan DR and the organizing Committee: Summary and Recommendations of the Fourth International Workshop-Conference on Gestational Diabetes. Diabetes Care 21(Suppl 2): B161-B167, 1998. 64. Coustan DR, Schwartz RM, Gagnon DE, VanDorsten JP and the Society for Maternal-Fetal Medicine: The distribution, practice, and attitudes of maternal-fetal medicine specialists. American Journal of Obstetrics and Gynecology 185:1218-1225, 2001. 65. HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome (HAPO) study. International Journal of Gynecology & Obstetrics 2002; 78: 69-77. 66. Coustan DR: Pharmacological management of gestational diabetes: an overview. Diabetes Care 30(Suppl 2):S206-S208, 2007. 67. Metzger BE, Buchanan TA, Coustan DR et al: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30(Suppl 2):S251-S260, 2007. 68. Coustan DR: Discussant of Smirnakis KV, Plati A, Wolf M, Thadhani R, Ecker JL: Predicting gestational diabetes: choosing the optimal early serum marker. American Journal of Obstetrics and Gynecology 196:410.e1-410.e7, 2007. 69. Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR et al: ADA Consensus Statement: Managing preexisting diabetes for pregnancy. Diabetes Care 31:1060-1079, 2008.

Last updated 23 May 18 12

70. The HAPO Study Cooperative Research Group (DR Coustan, member of writing group): Hyperglycemia and adverse pregnancy outcomes. New England Journal of Medicine 358:1991-2002, 2008. 71. Coustan DR: Clinical Crossroads: A 40-year-old woman with diabetes contemplating pregnancy after gastric bypass surgery. Journal of the American Medical Association 299; 2550-2567, 2008. 72. The HAPO Study Cooperative Research Group (DR Coustan, member of writing group): Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes 58:453- 459, 2009. 73. Coustan DR, Lowe LP, Metzger BE: The hyperglycemia and adverse pregnancy outcome (HAPO) study: can we use the results as a basis for change? Journal of Maternal-Fetal and Neonatal Medicine 23:204-209, 2010. 74. The HAPO Study Cooperative Research Group (DR Coustan, member of writing group): Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with maternal body mass index. British J ObGyn 117:575-584, 2010. 75. The HAPO Study Cooperative Research Group (DR Coustan, member of writing group): Hyperglycemia and adverse pregnancy outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol 202:255e1-7, 2010. 76. Coustan DR, Lowe LP, Metzger BE: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol 202:654e1- 6, 2010. 77. Dudley DJ, Goldenberg R, Conway D, Silver RM, Saade GR, Varner MW, Pinar H, Coustan D, Bukowski R, Stoll B, Koch MA, Parker CB, Reddy U for the Stillbirth Research Collaborative Network: A new system for determining the causes of stillbirth. Obstetrics and Gynecology 116:254-260, 2010. 78. Coustan DR: Finding and treating gestational diabetes – does it help? Nature Reviews: Endocrinology. 6:540- 542, 2010. 79. Metzger BE, Persson B, Lowe LP, Dyer AR, Cruikshank JK, Deerochanawong C, Halliday HL, Hennis AJ, Liley H, Ng PC, Coustan DR, Hadden DR, Hod M, Oats JJN, and Trimble E for the HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics 126:e1545-e1552, 2010. 80. Parker CB, Hogue CJR, Koch MA, Marian Willinger, Uma Reddy, Vanessa R. Thorsten, Donald J. Dudley, Robert M. Silver, Donald Coustan, George R. Saade, Deborah Conway, Michael W. Varner, Barbara Stoll, Halit Pinar, Radek Bukowski, Marshall Carpenter, and Robert Goldenberg for the Stillbirth Collaborative Research Network: Stillbirth Collaborative Research Network: design, methods and recruitment experience. Paediatric and Perinatal Epidemiology 25:425-35, 2011. 81. Bukowski R, Carpenter M, Conway D, Coustan D, Dudley DJ, Goldenberg RL, Hogue CJ, Koch MA, Parker CB, Pinar H, Reddy UM, Saade GR, Silver RM, Stoll BJ, Varner MW, Willinger M for the Stillbirth Collaborative Research Network: Causes of death among stillbirths. Journal of the American Medical Association 306:459-468, 2011. 82. Bukowski R, Carpenter M, Conway D, Coustan D, Dudley DJ, Goldenberg RL, Hogue CJ, Koch MA, Parker CB, Pinar H, Reddy UM, Saade GR, Silver RM, Stoll BJ, Varner MW, Willinger M for the Stillbirth Collaborative Research Network: Association between stillbirth and risk factors known at the time of pregnancy confirmation . Journal of the American Medical Association. 306:2469-2479, 2011. 83. Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, Lowe LP, Coustan DR, Hod M, Oats JJN, Persson B, Trimble ER for the HAPO Study Cooperative Research Group: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: frequency of gestational diabetes mellitus (GDM) at collaborating centers based on IADPSG consensus panel recommended criteria. Diabetes Care 35:526-528, 2012. .

Last updated 23 May 18 13

84. Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, Persson B, Hod M, Oats JN for the HAPO Study Cooperative Research Group: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: Associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35:780-786, 2012. 85. Coustan DR: Point: The ADA and the IADPSG recommendations for diagnosing gestational diabetes should be used worldwide, Clin Chem 58: 1094-7, 2012. 86. Lowe LP, Metzger BE, Dyer AR, Lowe J, McCance DR, Lappin TRJ, Trimble ER, Coustan DR, Hadden DR, Hod M, Oats JJN, Persson B, for the HAPO Study Cooperative Research Group: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations of maternal A1c and glucose with pregnancy outcomes. Diabetes Care 35:574-580, 2012.

87. Conway DL, Hansen NI, Dudley DJ, Parker CB, Reddy UM, Silver RM, Bukowski R, Pinar H, Stoll BJ, Varner MW, Saade GR, Hogue C, Willinger M, Coustan D, Koch MA, Goldenberg RL for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Stillbirth Collaborative Research Network: An algorithm for the estimation of gestational age at the time of fetal death. Paediatric and Perinatal Epidemiology 27: 145-157, 2013.

88. Hogue CJR, Parker CB, Willinger M, Temple JR, Bann CM, Silver RM, Dudley DJ, Koch MA, Coustan DR, Stoll BJ, Reddy UM, Varner MW, Saade GR, Conway D, Goldenberg RL for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Stillbirth Collaborative Research Network Writing Group: A population-based case-control study of stillbirth: the relationship of significant life events to the racial disparity for African Americans. American Journal of Epidemiology 2013 Apr 15;177(8):755-67

89. Coustan DR: Review: Gestational Diabetes. Clinical Chemistry 2013; 59: 1310-1321,

90. Coustan DR: Commentary: Can a dietary supplement prevent gestational diabetes mellitus? Diabetes Care 2013; 36: 777-779.

91. Mendez-Figueroa H, Daley J, Lopes VV, Coustan DR: Predicting the need for medical therapy in patients with mild gestational diabetes. American Journal of Perinatology 2014; 31: 105-112.

92. Mendez-Figueroa H, Daley J, Lopes VV, Coustan DR: Comparing daily versus less frequent blood glucose monitoring in patients with mild gestational diabetes. J Maternal Fetal Neonatal Medicine 2013; 26: 1268- 1272.

93. Silver RM, Parker CB, Reddy UM, Goldenberg R, Coustan D, Dudley DJ, Saade GR, Stoll B, Koch MA, Conway D, Bukowski R, Hogue CJR, Pinar H, Moore J, Willinger M, Branch DW: Antiphospholipid antibodies in stillbirth. Obstetrics & Gynecology 2013; 122: 641-657.

94. Mendez-Figueroa H, Maggio L, Dahlke JD, Daley J, Lopes VV, Coustan DR, Rouse DJ: Treatment of severe insulin resistance in pregnancy with 500 units per milliliter of concentrated insulin. Obstetrics & Gynecology 2013; 122: 99-104..

95. Silver RM, Parker CB, Goldenberg R, Reddy UM, Dudley DJ, Saade GR, Hogue CJR, Coustan D, Koch MA, Conway D, Bukowski R, Pinar H, Stoll B, Moore J, Willinger M UM for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Stillbirth Collaborative Research Network. Bile acids in a multi-center, population-based case control study of stillbirth. Am J Obstet Gynecol 2014; 210: 460e1-9. 96.

97. Varner M, Silver RM, Hogue, CJR, Willinger M, Parker CB, Thorsten VR, Goldenberg RL, Saade GR, Dudley DJ, Coustan D, Stoll B, Bukowski R, Koch MA, Conway D, Pinar H, Reddy UM for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Stillbirth Collaborative Research

Last updated 23 May 18 14

Network. Association between stillbirth and illicit drug use and smoking during pregnancy. Obstetrics and Gynecology 2014; 123:113-125.

98. Pinar H, Goldenberg RL, Koch MA, Heim-Hall J, Hawkins H, Shehata B, Abramowsky C, Parker CB, Dudley DJ, Silver RM, Stoll B, Carpenter M, Saade G, Moore J, Conway D, Varner MW, Hogue CJR, Coustan DR, Sbrana E, Thorsten V, Willinger M, Reddy UM. Placental findings in singleton stillbirths: a case control study. Obstetrics and Gynecology 2014; 123: 325-336.

99. Starikov RS, Inman K, Chien EK, Anderson BL, Rouse DJ, Lopes V, Coustan DR: Can hemoglobin A1c in early pregnancy predict adverse pregnancy outcomes in diabetic patients? Journal of Diabetes and its Complications. 2014: 28:203-207.

100. Starikov R, Bohrer J, Goh W, Kuwahara M, Chien EK, Lopes V, Coustan D: Hemoglobin A1c in pregestational diabetic gravidas and the risk of congenital heart disease in the fetus. Pediatric Cardiology. 2013; 34: 1716-1722.

101. Bukowski R, Hansen NI, Willinger M, Reddy UM, Parker CB, Pinar H, Silver RM, Dudley DJ, Stoll BJ, Saade GR, Koch MA, Rowland Hogue CJ, Varner MW, Conway DL, Coustan D, Goldenberg RL; Eunice Kennedy Shriver National Institute of Child Health and Human Development Stillbirth Collaborative Research Network: Fetal growth and risk of stillbirth: a population-based case-control study. PLoS Med. 2014 Apr 22;11(4):e1001633.

102. McIntyre HD, Metzger BE, Coustan DR, Dyer AR, Hadden DR, Hod M, Lowe LP, Oats JJ, Persson B: Counterpoint: establishing consensus in the diagnosis of GDM following the HAPO study. Curr Diab Rep. 2014; 14: 497.

103. Mendez-Figueroa H, Daley J, Breault P, Lopes VV, Paine V, Goldman D, Francis MJ, Delgado B, Coustan DR: Impact of an intensive follow-up program on the postpartum glucose tolerance testing rate. Arch Gynecol Obstet. 2014; 289: 1177-83.

104. Mendez-Figueroa H, Dahlke JD, Daley J, Lopes VV, Coustan DR. Prediction of abnormal postpartum glucose tolerance testing in mild gestational diabetes mellitus. J Reprod Med. 2014; 59:393-400.

105. Coustan DR. Diagnosis of gestational diabetes. Scand J Clin Lab Invest Suppl. 2014;244:27-33.

106. Hogue CJ, Parker CB, Willinger M, Temple JR, Bann CM, Silver RM, Dudley DJ, Moore JL, Coustan DR, Stoll BJ, Reddy UM, Varner MW, Saade GR, Conway D, Goldenberg RL; Eunice Kennedy Shriver National Institute of Child Health and Human Development Stillbirth Collaborative Research Network Writing Group. The association of stillbirth with depressive symptoms 6-36 months post-delivery. Paediatr Perinat Epidemiol. 2015 Mar; 29(2): 131-43.

107. Coustan DR. Perfect may be the enemy of good in diagnosing gestational diabetes. BJOG. 2016 Jan http://dx.doi.org/10.1111/1471-0528.13857.

108. Coustan DR: An ounce of prevention… Editorial in Am J Obstet Gynecol 2017: 216:338-39.

109. Page JM, Christiansen-Lindquist L, Thorsten V, Parker CB, Reddy UM, Dudley DJ, Saade GR, Coustan D, Rowland Hogue CJ, Conway D, Bukowski R, Pinar H, Heuser CC, Gibbins KJ, Goldenberg RL, Silver RM. Diagnostic Tests for Evaluation of Stillbirth: Results From the Stillbirth Collaborative Research Network. Obstet Gynecol. 2017 Apr;129(4):699-706.

110. Sperling JD, Maggio L, Has P, Daley J, Khander A, Coustan DR. Prenatal care adherence and neonatal intensive care unit admission or stillbirth among women with gestational and preexisting diabetes mellitus. Am J Perinatol 2017 (Epub ahead of print) Last updated 23 May 18 15

111. Sperling JD, Maggio L, Has P, Daley J, Coustan DR, Werner EF. Insulin delivery method and admission for glycemic control in pregnant women with type 1 diabetes mellitus. Am J Perinatol 2017 (Epub ahead of print)

112. Bukowski R, Hansen NI, Pinar H, Willinger M, Reddy UM, Parker CB, Silver RM, Dudley DJ, Stoll BJ, Saade GR, Koch MA, Hogue C, Varner MW, Conway DL, Coustan D, Goldenberg RL; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Stillbirth Collaborative Research Network (SCRN). Altered fetal growth, placental abnormalities, and stillbirth. PLoS One 2017; Aug 18: 12(8):e0182874.

113. Coustan DR, Barbour L. Editorial: Insulin vs glyburide for gestational diabetes. JAMA 2018.

114. Page JM, Thoirsten V, Reddy UM, Dudley DJ, Hague CJR, Saade GR, Pinar H, Parker CB, Conway D, Stoll BJ, Coustan D, Bukowski R, Varner MW, Goldenberg RL, Gibbins K, Silver RM. Potentially preventable stillbirth in a diverse US cohort. Obstetrics and Gynecology 23018; 131: 336-343. 115. Harrison MS, Thorsten VR, Dudley DJ, Parker CB, Koch MA, Hogue CR, Stoll BJ, Silver RM, Varner MW, Pinar MH, Coustan DR, Saade GR, Bukowski RK, Conway DL, Willinger M, Reddy UR, Goldenberg RL. Stillbirth, inflammatory markers, and obesity: results from the Stillbirth Collaborative Research Network. American Journal of Perinatology 2018 Apr 2. doi: 10.1055/s-0038-1639340. [Epub ahead of print]. 116. Wexler DJ, Powe CE, Barbour LA, Buchanan T, Coustan DR, Corcoy R, Damm P, Dunne F, Feig DS, Ferrara A, Harper LM, Landon MB, Meltzer SJ, Metzger BE, Roeder H, Rowan JA, Sacks DA, Simmons D, Umans JG, Catalano PM. Obstet Gynecol. 2018 Aug;132(2):496-505.

117. Barbour LA, Scifres C, Valent AM, Friedman JE, Buchanan TA, Coustan D, Aagaard K, Thornburg K, Catalano PM, Galan HL, Hay WW Jr, Frias AE, Shankar K, Simmons RA, Moses RG, Sacks DA, Loeken MR. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol 2018; 219(4): 367.e1-367.e7.

Other publications:

1. Kling A, Coustan D: Somato-motor, autonomic and affective responses to subcortical stimulation in the infant cat. Federation Proceedings 23:359, 1964. 2. Coustan DR, Lewis SB: Clinical approaches to diabetes in pregnancy. Contemporary Ob/Gyn 7:27, 1976. 3. Coustan DR: Symposium on gestational diabetes. Contemporary Ob/Gyn 8, 1976. 4. Coustan DR: contributor to Obstetrics and Gynecology: self assessment and review Pretest Service inc., Wallingford, Conn., 1977. 5. Coustan DR, Lewis SB: Clinical approaches to diabetes in pregnancy. Contemporary Obstetrics and Gynecology 51:306, 1978. 6. Coustan DR, De Cherney AH: The postoperative pain-anxiety circuit: an obstetrical perspective. Hospital Practice 41, 1980. 7. Coustan DR: Recent advances in the management of diabetic pregnancy. Clinics in Perinatology WB Saunders, 7:299, 1980. 8. Coustan DR: contributor to Patient Management Problems in Obstetrics and Gynecology AH DeCherney, ed. ARCO publishing co., 1980. 9. Coustan DR: The pregnant patient with overt diabetes: practical guide to management. Part 1. Perinatology-Neonatology 5:27, 1981.

Last updated 23 May 18 16

10. Coustan DR: The pregnant patient with overt diabetes: practical guide to management. Part 2. Perinatology-Neonatology 6:29 1982. 11. Oh W, Coustan D: Intrauterine fetal growth retardation: perinatal diagnosis and management. Annales Nestle 40:17, 1982. 12. Coustan DR, Cowett R: Perinatologists view repeat cesareans. Contemporary Ob/Gyn 20:223, 1982. 13. Coustan DR: Home glucose monitoring becomes more sophisticated. Contemporary Ob/Gyn 20:7, 1983. 14. Coustan DR: Hodgkin's disease and future reproduction. International Correspondence Society of Obstetricians and Gynecologists-Collected Letters 24:15, 1983. 15. Coustan DR and Carpenter MW: The use of medications in pregnancy. Medical Times and Resident Staff Physician, June 1984 and Dec 1984. 16. Coustan DR and Carpenter MW: Detection and treatment of gestational diabetes. Clinical Obstetrics and Gynecology (ed. S. Gabbe) 28:507-515, 1985. 17. Coustan DR: Choosing prophylactic insulin for the gestational diabetic. Contemporary Ob/Gyn 25:31-48, 1985. 18. Gabbe S, Coustan D, Dooley S: Teleconference: diabetes and pregnancy: what are the best techniques for control? Data Centrum 2:11-16, 1985. 19. Contributor to Precis III, American College of Obstetricians and Gynecologists, 1986. 20. Coustan DR: Anfragen an die Redaktion: Welche Methoden der Zervixreifung vor der Geburtseinleitung sind am effekt ivsten? Zentralblatt fur Gynakologie 108:946-948, 1986. 21. Coustan DR: Anfragen and die Redaktion: Welcher Geburtsmodus ist bei untergewichtigen Kindern in Beckenendlage zu bevogzugen? Zentralblatt fur Gynakologie 108: 1021-1023, 1986. 22. Coustan DR: Is insulin necessary for gestational diabetes? Contemporary Ob/Gyn 29:35-51, 1987. 23. Hoegsberg B and Coustan DR: Gestational diabetes: diagnosis and current management. The Female Patient 12:67-72, 1987. 24. Coustan DR: Clinical aspects of antenatal enhancement of pulmonary maturation. Clinics in Perinatology L Stern, ed. 14: 697-712, Philadelphia: WB Saunders, 1987. 25. Coustan DR: Gestational diabetes. Obstetrics and Gynecology Forum II 1988, 4:1-4, 13. 26. Coustan DR: Pregnancy in a young diabetic. Hospital Practice 24:75-88, 1989. 27. Chez RA, Coustan DR, Gabbe SG, Langer O: Meeting the challenge of gestational diabetes. Contemporary Ob/Gyn 34:120-140, 1989. 28. Contributor to Precis IV, American College of Obstetricians and Gynecologists, 1990. 29. Abrams RS and Coustan DR: Gestational Diabetes Update. Clinical Diabetes 8:17-24, 1990. 30. Coustan DR and Carr SR: Cocaine use during pregnancy. Rhode Island Medical Journal 73:249-252, 1990. 31. Coustan DR: Maternal insulin to lower the risk of fetal macrosomia in diabetic pregnancy. Clinical Obstetrics and Gynecology 34:288-295. 1991. 32. Coustan DR: A guide for managing gestational diabetes. Contemporary Ob/Gyn 36(6):19-32, 1991. 33. Coustan DR: Management of gestational diabetes. Clinical Obstetrics and Gynecology 34:558-564, 1991. 34. Coustan DR: Insulin treatment for gestational diabetes. Diabetes, Nutrition & Metabolism 3 (Suppl 2):57- 60, 1990. Last updated 23 May 18 17

35. Coustan DR: Screening and diagnosis of gestational diabetes. Chapter 3 in Baillière’s Clinical Obstetrics and Gynaecology 5 (2):293-313, 1991. 36. Coustan DR: Screening and diagnosis of gestational diabetes. Israel Journal of Medical Sciences 27:503- 509, 1991. 37. Carr SR and Coustan DR: What’s the latest in glucose monitors? Contemporary Ob/Gyn 36: 15 April 92, 9- 12. 38. Coustan DR: Commentary on the O’Sullivan and Mahan Criteria. Diabetes Spectrum 5:31-33, 1992. 39. Coustan DR: Does gestational diabetes exist? What shall we do about it? The World of Obstetrics and Gynecology 44:39-48, 1992. 40. Coustan DR: Methods of screening for and diagnosing of gestational diabetes. Clinics in Perinatology 20:593-602, 1993. 41. Coustan DR: Reproductive medicine and family planning - 2018. Rhode Island Medicine 77:167, 1994. 42. Coustan DR: Screening and diagnosis of gestational diabetes. Seminars in Perinatology Diabetes in Pregnancy and the Newborn. 18:407-413, 1994. 43. Coustan DR: Screening and testing for gestational diabetes. Obstetrics and Gynecology Clinics of North America 23:125-136, 1996. 44. Coustan DR: Gestational diabetes. Contemporary Ob/Gyn 41: 18-22, 1996. 45. Coustan DR: Debate: Is preconception counseling for women with diabetes cost-effective? On the Pro Side. Diabetes Spectrum 10:195-200, 1997. 46. Coustan DR: Diabetes mellitus. Precis: Obstetrics Washington, DC: American College of Obstetricians and Gynecologists, 1998. Pp 58-61. 47. Coustan DR: Use of metronidazole during pregnancy. Pediatric Infectious Disease Journal 18:79, 1999. 48. Coustan DR: Making the diagnosis of gestational diabetes. Clinical Obstetrics and Gynecology 43:99-105, 2000. 49. Coustan DR: Contributor to Precis: An Update in Obstetrics and Gynecology: Obstetrics (2nd edition) Washington, DC: ACOG, 2000. 50. Coustan DR: Oral hypoglycemic agents for the ob/gyn. Contemporary Ob/Gyn 46:44-63, 2001. 51. Coustan DR: Gestational Diabetes. ACOG Practice Bulletin #30. Washington, DC: American College of Obstetricians and Gynecologists, September 2001. 52. Coustan DR: Diabetes mellitus. Precis: Obstetrics (3rd edition) Washington, DC: American College of Obstetricians and Gynecologists, 2005. Pp 93-96. 53. Russell MA, Coustan DR: Diabetes in Pregnancy. The Female Patient 30:40-51, 2005. 54. Fuchs KM and Coustan DR: Immunosuppresant therapy in pregnant organ transplant recipients. Seminars in Perinatology 31:363-371, 2007. 55. Metzger B, Coustan D, Dyer A, Hadden D et al: New findings in gestational diabetes – the HAPO Study. Diabetes Voice 54:25-18, May 2009. 56. Paglia MJ, Coustan DR: The use of oral antidiabetic medications in gestational diabetes mellitus. Current Diabetes Reports 9:287-290, 2009. 57. Coustan DR: Examining the Evidence: Is metformin more effective than glyburide for treating gestational diabetes? OBG Management 22:18-21, 2010. Last updated 23 May 18 18

58. Coustan DR: Diabetes mellitus. Precis: Obstetrics (4th edition) Washington, DC: American College of Obstetricians and Gynecologists, 2010. Pp. 133-138. 59. Coustan DR: Diabetes in Pregnancy (Gestational and Preexisting). DVD 8 in Comprehensive Review of Obstetrics-Gynecology (Eds RL Barbieri and ER Norwitz). CME Info, October 2010. 60. Paglia MJ and Coustan DR: Gestational diabetes: evolving diagnostic criteria. Current Opinion in Obstetrics & Gynecology. 23:72-75, 2011. 61. Coustan DR and Hod M: Ask The Experts: Management of diabetes during pregnancy. Diabetes Management 2:281-288, 2012. 62. Coustan D: Commentary: Treating mild gestational diabetes yields benefits with little or no harm. Evidence Based Medicine 2013: Epub ahead of print. 63. Coustan DR: Recurrent GDM and the development of type 2 diabetes have similar risk factors. Endocrine 53(3): 634-5, 2016. 64. Sacks DB, Coustan DR, Cundy T, Donovan L, Hod M. Gestational Diabetes Mellitus: Why the Controversy? Clin Chem 2018 Mar;64(3):431-438.

Books:

1. Coustan DR, Garvey S: The Baby Team: A Positive Approach to Pregnancy with Diabetes Monoject Division of Sherwood Medical, 1979. 2. Berkowitz RL, Coustan DR, Mochizuki T: Handbook for Prescribing Medications During Pregnancy Boston: Little Brown and Company, 1981. 3. Berkowitz RL, Coustan DR, and Mochizuki TK: Handbook for Prescribing Medications During Pregnancy (2nd edition) Boston: Little Brown and Company, 1986. 4. Weiss PAM and Coustan DR (eds): Gestational Diabetes Vienna: Springer-Verlag, 1988. 5. Reece EA and Coustan DR (eds): Diabetes Mellitus in Pregnancy: Principles and Practice New York: Churchill Livingstone, 1988. 6. Lee RV, Barron WM, Cotton DB, Coustan DR (eds): Current Obstetric Medicine (Vol 1) St Louis: Mosby Year Book, 1991. 7. Coustan DR, guest editor: Symposium on Diabetes in Pregnancy. Clinical Obstetrics and Gynecology 34:479-580, 1991. 8. Lee RV, Barron WM, Cotton DB, Coustan DR (eds): Current Obstetric Medicine (Vol 2) St. Louis: Mosby Year Book, 1993. 9. Coustan DR: Contributing editor to Medical Management of Pregnancy Complicated by Diabetes Alexandria, Virginia: American Diabetes Association, 1993. 10. Coustan DR: Guest Editor of Seminars in Perinatology Diabetes in Pregnancy and the Newborn. Volume 18 No. 5, October 1994. 11. Coustan DR (ed), Haning RV Jr and Singer DB (assoc eds): Human Reproduction: Growth and Development Boston: Little Brown, 1995. 12. Lee RV, Garner PR, Barron WM, Coustan DR (eds): Current Obstetric Medicine (Vol 3) St. Louis: Mosby, 1995. 13. Reece EA and Coustan DR (eds): Diabetes Mellitus in Pregnancy (2nd edition) New York: Churchill Livingstone, 1995. 14. Lee RV, Garner PR, Barron WM, Coustan DR (eds): Current Obstetric Medicine (Vol 4) St. Louis: Mosby, 1996.

Last updated 23 May 18 19

15. Coustan DR, Mochizuki TK: Handbook for Prescribing Medications During Pregnancy (Third edition). Philadelphia: Lippincott- Raven, 1998. 16. Reece EA, Coustan DR, Gabbe SG (eds): Diabetes Mellitus in Women (3rd edition) Philadelphia: Lippincott Williams & Wilkins, 2004. 17. Kitzmiller JL, Jovanovic L, Brown F, Coustan D, Reader DM, editors. Managing Preexisting Diabetes and Pregnancy, Alexandria, Virginia, American Diabetes Association, 2008. 18. American Diabetes Association: Medical Management of Pregnancy Complicated by Diabetes (5th edition). DR Coustan editor. Alexandria, Virginia: ADA, 2013. 19. American College of Obstetricians and Gynecologists: Clinical Updates in Women’s Health Care: Diabetes Mellitus. D.R. Coustan. (Volume XII, Number 3, July 2013). 20. Reece EA, Coustan DR (eds): Diabetes & Obesity in Women (4th edition) Philadelphia: Walters Kluwer, 2018.

Chapters in Books:

1. Coustan DR, Warshaw JB: The diabetic pregnancy and its outcome. In The Diabetic Pregnancy, Mead Johnson Symposium on Perinatal and Developmental Medicine #13, 70, 1978. 2. Felig P, Coustan DR: Diabetes Mellitus. Chapter in Medical Complications During Pregnancy (2nd edition) GN Burrow and TF Ferris eds. WB Saunders, pp 36-61, 1982. 3. Coustan DR: Gestational Diabetes. Chapter in Protocols for High-Risk Pregnancies JT Queenan and JC Hobbins eds. Medical Economics Press, pp 36-61, 1982. 4. Coustan DR: Diabetes in Pregnancy. Chapter in Perinatal Medicine in Primary Practice JB Warshaw and JC Hobbins eds. Addison-Wesley Inc. pp 115-118, 1982. 5. Coustan DR: Diabetic Ketoacidosis. Chapter in Critical Care of the Obstetric Patient RL Berkowitz ed. Churchill Livingstone Inc. pp 411-430, 1983. 6. Coustan DR, Plotz RD: The laboratory in diseases associated with pregnancy. Chapter in Laboratory Medicine in Clinical Practice HN Mandell ed. John Wright PSG, Inc. pp 353-386, 1983. 7. Coustan DR: Management of the pregnant diabetic. Chapter 10 in Contemporary Issues in Endocrinology and Metabolism: Diabetes Mellitus -Management and Complications JM Olefsky and R Sherwin eds. Churchill Livingstone Inc. pp. 311-330, 1985. 8. Coustan DR: Hyperglycemia-hyperinsulinemia: effect on the infant of the diabetic mother. Chapter in Diabetes and Pregnancy: Teratology, Toxicity and Treatment (eds. L. Jovanovic, C.M. Peterson, K. Fuhrmann). New York: Praeger, Pp. 131-156, 1986. 9. Carpenter MW and Coustan DR: Screening for diabetes in pregnancy. Chapter in Diabetes and Pregnancy: Teratology, Toxicity and Treatment eds. L. Jovanovic, C.M. Peterson, K. Fuhrmann). New York: Praeger, Pp. 245-262, 1986. 10. Coustan DR: Diabetes in pregnancy. Chapter in Principles of Diabetes Management (ed. M. Bergman). New York: Medical Examination Publishing Company (Elsevier), Pp. 190-207, 1987. 11. Coustan DR and Felig P: Diabetes mellitus. Chapter in Medical Complications During Pregnancy (3rd edition) GN Burrow and TF Ferris eds Philadelphia: WB Saunders, pp 34-64, 1987. 12. Coustan DR: The use of prophylactic insulin in women with gestational diabetes. Chapter 12 in Gestational Diabetes PAM Weiss and DR Coustan, eds. Vienna: Springer-Verlag, 1988. Pp. 134-141.

Last updated 23 May 18 20

13. Coustan DR: Management of gestational diabetes. Chapter 19 in Diabetes Mellitus in Pregnancy: Principles and Practice EA Reece and DR Coustan, eds. New York: Churchill Livingstone, 1988. Pp. 441-452. 14. Coustan DR: Delivery, timing, mode and management. Chapter 24 in Diabetes Mellitus in Pregnancy: Principles and Practice EA Reece and DR Coustan, eds. New York: Churchill Livingstone, 1988. Pp. 525-533 15. Coustan DR: Perinatal morbidity and mortality. Chapter 25 in Diabetes Mellitus in Pregnancy: Principles and Practice EA Reece and DR Coustan, eds. New York: Churchill Livingstone, 1988. Pp. 537-545. 16. Oh W, Coustan DR: Intrauterine Growth Retardation. Chapter 5 in Textbook of Gastroenterology and Nutrition in Infancy, Second Edition. E. Lebenthal ed., Raven Press, Ltd., New York: pp 35-44, 1989. 17. Coustan DR: Diabetes Mellitus. Chapter 49 in Assessment & Care of the Fetus, Physiological, Clinical, and Medicolegal Principles R Eden and F. Boehm, eds., Appleton & Lange, Connecticut. pp 693-710, 1989. 18. Coustan DR: Prevention of complications during labor and delivery. Chapter 10 in Prevention of Developmental Disabilities SM Pueschel and JA Mulick, eds. Baltimore: Paul H. Brookes, 1990. Pp. 157- 178. 19. Coustan DR: Diabetes mellitus in pregnancy. Chapter in Difficult Medical Management RB Taylor ed. Philadelphia: WB Saunders, 1990. Pp. 195-200. 20. Coustan DR: Diabetes and pregnancy. Chapter 27 in Surgical Management of the Diabetic Patient M Bergman and GA Sicard, eds. New York: Raven Press, 1991. Pp. 363-370. 21. Coustan DR: Gestational diabetes mellitus. Chapter 2 in Therapy for Diabetes Mellitus and Related Disorders HE Lebovitz, ed. Alexandria, Va: American Diabetes Association, 1991. Pp. 10-15. 22. Coustan DR: Diabetes in pregnancy. Chapter 12 in Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant (fifth edition) eds AA Fanaroff and RJ Martin St. Louis: Mosby Year Book, 1992. Pp 199-204. 23. Coustan DR: Diabetes mellitus complicating pregnancy. Chapter 27 in Vol 2, Gynecology and Obstetrics (eds JJ Sciarra and W Droegemueller) Philadelphia, Rev 1992. 24. Coustan DR: Nonprescription drugs and alcohol: abuse and effects in pregnancy. Chapter 22 in Medicine of the Fetus and Mother (eds EA Reece, JC Hobbins, MJ Mahoney, RH Petrie) Philadelphia: JB Lippincott, 1992. Pp 317-327. 25. Coustan DR: Cervical Cerclage. Chapter 63 in Gynecologic and Obstetric Surgery (Ed DH NIchols) St. Louis: Mosby Year Book, 1993. Pp 1031-1047. 26. Coustan DR: Contributor to Medical Management of Pregnancy Complicated by Diabetes Alexandria Va: American Diabetes Association, 1993. 27. Coustan DR: Gestational diabetes. Chapter 25 in Management of High-Risk Pregnancy (3rd edition, ed JT Queenan). Boston: Blackwell Scientific, 1994. Pp 258-262 28. Coustan DR: Gestational diabetes mellitus. Chapter 2 in Therapy for Diabetes Mellitus and Related Disorders (Second edition) HE Lebovitz, ed. Alexandria, Va: American Diabetes Association, 1994. Pp. 11-16. 29. Buchanan TA and Coustan DR: Diabetes Mellitus. Chapter 2 in Medical Complications During Pregnancy (4th edition) GN Burrow and TF Ferris eds Philadelphia: WB Saunders, 1995. pp 29-61. 30. Coustan DR: Screening and diagnosis of gestational diabetes. Seminars in Perinatology Diabetes in Pregnancy and the Newborn. 18:407-413, 1994. 31. Coustan DR: Management of gestational diabetes. Chapter 17 in Reece EA and Coustan DR (eds): Diabetes Mellitus in Pregnancy (2nd edition) New York: Churchill Livingstone, 1995. Pp 277-286. 32. Coustan DR: Delivery: timing, mode and management. Chapter 22 in Reece EA and Coustan DR (eds): Diabetes Mellitus in Pregnancy (2nd edition) New York: Churchill Livingstone, 1995. Pp 353-360. 33. Coustan DR: Perinatal mortality and morbidity. Chapter 23 in Reece EA and Coustan DR (eds): Diabetes Mellitus in Pregnancy (2nd edition) New York: Churchill Livingstone, 1995. Pp. 361-368.

Last updated 23 May 18 21

34. Coustan DR: Gestational diabetes. Chapter 35 in Diabetes In America (2nd edition) National Diabetes Data Group, Washington DC, 1995. Pp. 703-718. 35. Coustan DR: Gestational diabetes. Chapter 37 in Protocols for High-Risk Pregnancies (3rd edition) eds JT Queenan and JC Hobbins Cambridge, MA: Blackwell Science, 1996. Pp. 249-252. 36. Coustan DR: Diagnosis and management of diabetes mellitus in pregnancy. Chapter 13 in Volume 3 Gynecology and Obstetrics (ed. J Sciarra) , 1996 revision. 37. Coustan DR: Diabetes in pregnancy. Chapter 14 in Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant (sixth edition) eds AA Fanaroff and RJ Martin St. Louis: Mosby Year Book, 1997. Pp 258-263. 38. Coustan DR: Gestational diabetes mellitus. Chapter 3 in Therapy for Diabetes Mellitus and Related Disorders (Third edition) HE Lebovitz, ed. Alexandria, Va: American Diabetes Association, 1998. Pp. 20- 26. 39. Carr SR, Coustan DR: Nonprescription drugs and alcohol: abuse and effects in pregnancy. Chapter 20 in Medicine of the Fetus and Newborn (second edition) Eds EA Reece and JC Hobbins. Philadelphia: Lippincott-Raven, 1999, Pp 315-326. 40. Coustan DR: Gestational diabetes. Chapter 24 in Management of High-Risk Pregnancy (fourth edition) Ed John T. Queenan. Malden, MA: Blackwell Science, 1999. Pp. 262-265. 41. Coustan DR: Cervical Cerclage. Chapter 57 in Gynecologic and Obstetric Surgery (second edition (Eds DH Nichols and DL Clarke-Pearson) St. Louis: Mosby, 2000. Pp 1049-1065. 42. Coustan DR: Gestational diabetes. Chapter 33 in Protocols for High-Risk Pregnancies (4th edition) eds JT Queenan , JC Hobbins and CYU Spong. Malden MA: Blackwell Publishing, 2005. Pp. 224-234. 43. Paglia MJ and Coustan DR: Uso de medicações orais no diabetes melito gestacional. Chapter 18 in Doenças Endócrinas & Gravidez ed Lucio Vilar.Rio de Janeiro: Medbook, 2011. Pp227-240. 44. Lowe LP, Metzger BE, Dyer AR, Coustan DR, Hadden DR, Hod M, Oats JJN, Persson B, Trimble ER and the HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: an overview. In: Kim C, Ferrara A, eds. Gestational Diabetes During and After Pregnancy. London: Springer-Verlag; 2010:17-34. 45. Coustan DR and Starikov R: Effects of maternal medication on the fetus and newborn. Chapter 2 in Evidence-Based Handbook of Neonatology (Ed W. Oh).Singapore: World Scientific Publishing Co, 2010:25-40. 46. Coustan DR: Diabetes in Pregnancy. Chapter 1 in Clinical Maternal-Fetal Medicine (2nd edition), eds Winn HN, Chervenak FA and Romero R. on line edition. 2011; Informa Health Care. 47. Angelini DJ, O’Brien B, Singer J, Coustan DR: Midwifery and obstetrics: twenty years of collaborative academic practice. Obstet Gynecol Clin North America 39; 2012: 335-346. 48. Coustan DR. Diagnosis of Gestational Diabetes. Chapter 2 in Nutrition and Diet in Maternal Diabetes eds R Rajendram, VR Preedy, VB Patel. Humana Press. 2017. 17-28. 49. Coustan DR. Perinatal morbidity and mortality. Chapter 15 in Reece EA, Coustan DR (eds): Diabetes & Obesity in Women (4th edition) Philadelphia: Walters Kluwer, 2018, 198-203. 50. Coustan DR. Testing for gestational diabetes. Chapter 17 in Reece EA, Coustan DR (eds): Diabetes & Obesity in Women (4th edition) Philadelphia: Walters Kluwer, 2018, 217-227. 51. Coustan DR. Delivery: Timing, Mode and Management. Chapter 34 in Reece EA, Coustan DR (eds): Diabetes & Obesity in Women (4th edition) Philadelphia: Walters Kluwer, 2018, 425-431. 52.

Corporate Authorship or Multicenter Trials

Last updated 23 May 18 22

1. HAPO Study Cooperative Research Group: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. International Journal of Gynecology & Obstetrics 78: 69-77, 2002. 2. Nesbitt GS, Smye M, Sheridan B, Lappin TRJ, Trimble ER on behalf of the HAPO Study Cooperative Research Group: Integration of local and central laboratory functions in a worldwide multicenter study: Experience from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Clinical Trials 3:397-407, 2006. 3. International Association of Diabetes & Pregnancy Study Groups Consensus Panel Writing Group and the HAPO Study Steering Committee: The diagnosis of gestational diabetes: new paradigms or status quo? J Matern Fetal Neonatal Med 25; 2012: 2564-2569.

Letters to the Editor:

1. Coustan DR: Antiarrhythmic agents during pregnancy. J.A.M.A. 247:303, 1982. 2. Coustan DR: Gestational Diabetes. American Journal of Obstetrics and Gynecology 145:893, 1983. 3. Coustan DR: Insulin requirements during labor. American Journal of Obstetrics and Gynecology 146: 116, 1983. 4. Coustan DR: Reply to "Some questions on managing diabetic pregnancy. Contemporary Ob/Gyn 30:13, 1983. 5. Coustan DR: Reply to "Gestational diabetes and birth trauma." American Journal of Obstetrics and Gynecology 152:919, 1985. 6. Coustan DR: Reply to letter concerning: "Maternal age and screening for gestational diabetes: a population- based study." Obstetrics and Gynecology 74:287, 1989. 7. Kitzmiller JL, Buchanan T, Coustan DR: Comment on "Pre-pregnancy clinics for diabetic women. Lancet 340:919-920, 1992. 8. Coustan DR: Regarding "Comparison of Prenatal Glucose Screening in the Fasted vs Fed State.” Journal of Maternal-Fetal Investigation 3:63, 1993. 9. Coustan DR: Regarding “Pregnancy outcomes in women with and without gestational diabetes mellitus according to the International Association of the Diabetes in Pregnancy Study Groups Criteria.” Obstetrics and Gynecology 2013; 121: 377. 10. Mendez-Figueroa H, Coustan DR: Response to: Improving postpartum screening rates. Arch Gynecol Obstet. 2014; 289:1161. 11. Coustan DR: Re: Follow-up of women with previous gestational diabetes. Acta Diabetol. 2015 June 27 (Epub ahead of print) 12. Coustan DR: Costs of gestational diabetes. Diabetic Medicine 2015 Sept 11 (Epub ahead of print). 13. Coustan DR: Re: Follow-up of women with previous gestational diabetes. Acta Diabetologica 2016; 53: 133.

Book and Article Reviews:

1. Coustan DR: The Diabetic Pregnancy: A Perinatal Perspective IR Merkatz and PAJ Adams eds. Grune and Stratton. New York, 1979. N. Engl. J. Med. 1980. 2. Coustan DR: Primary Health Care for Obstetricians and Gynecologists WF Baden and DR Thornton eds. Williams and Wilkins. Baltimore, 1980. N. Engl. J. Med. 1981. 3. Coustan DR: Management of Labor WR Cohen and EA Friedman eds. University Park Press. Baltimore, 1983. N. Engl. J. Med. 309:1589, 1983. 4. Coustan DR: Commentary on Mills et al: Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 318:671, 1988 Diabetes Spectrum 3:157-158, 1990.

Last updated 23 May 18 23

5. Coustan DR: Review: Using the screening test for gestational diabetes as a diagnostic test. International Diabetes Monitor 8(5):5-6, 1996. 6. Coustan DR: Review: Determinants of perinatal outcome in GDM. International Diabetes Monitor 9(4):8- 9, 1997. 7. Coustan DR: Review: Post-breakfast blood glucose for managing gestational diabetes. International Diabetes Monitor 10(2):12-13, 1998. 8. Coustan DR: Review: Is prepregnancy metabolic control practical? International Diabetes Monitor 10(6):14-15, 1998. 9. Coustan DR: Review: Thresholds for screening tests for GDM. International Diabetes Monitor 11(3):7-8, 1999. 10. Coustan DR: Review: Diabetic nephropathy and pregnancy. International Diabetes Monitor 13(3):22-24, 2001. 11. Coustan DR: Treating mild gestational diabetes yields benefits with little or no evidence of harms. Evid Based Med. 2014;19: 88.

Webinars

1. Webinar: New Recommendations for Diagnosis of Hyperglycemia in Pregnancy. American Association for Clinical Chemistry. 12 June 2012. 2. Webinar: Update on Gestational Diabetes. National Perinatal Information Center/Quality Analytic Services. 27 February 2013. 3. Webinar: New Developments in Diagnosing and Managing Gestational Diabetes. American Association for Clinical Chemistry. 15 January 2014. Other Media 1. Coustan DR: Diabetes during pregnancy. Audio-Digest Obstetrics Board Review. June 2014. 2. Coustan DR: Video-Conference on gestational diabetes. Department of Endocrinology, King Edward Memorial Hospital., Seth Gordhandas Sunderas medical College, Mumbai India. 23 Jan 18.

Presentations/Abstracts

1. Murray W, Lewis SB, Coustan DR, Wallin D, Daane T: Improved management of the pregnant diabetic. ACOG, Armed Forces District Meeting, Las Vegas, 1974. 2. Kyuza H, Lewis SB, Murray WK, Coustan DR, Daane TA, Wallin JD, Rubenstein AH: Circadian variation of serum glucose, C-peptide immunoreactivity and free insulin in normal and insulin-treated pregnant subjects. Endocrine Society, 1975. 3. Coustan DR: Insulin therapy of gestational diabetes. Prize paper. ACOG, District I, Bermuda, 1977. 4. Soman VJ, Coustan DR, Felig P: Dissociation between insulin binding to monocytes and insulin sensitivity in normal pregnancy. Endocrine Society, Anaheim, 1979. 5. Coustan DR: Tight control of diabetes in pregnancy. ACOG, District I, Israel, 1979. 6. Carpenter MW, Grannum P, Silverman R, Coustan DR, and Hobbins JC: Intrauterine morphometric measurements with ultrasound in growth retarded and diabetic pregnancies. Society for Gynecologic Investigation, San Diego, 1979.

Last updated 23 May 18 24

7. Carpenter MW, Coustan DR: Selecting thresholds for further testing in a screening test for gestational diabetes. Society of Perinatal Obstetricians, San Antonio, 1981. 8. Rudolf MCJ, Tamborlane W, Sherwin R, Felig P, Genel M, Coustan DR: Is insulin pump treatment effective in managing the pregnant diabetic? Asia-Oceania Diabetes Association, Honolulu, 1981. 9. Rudolf MCJ, Tamborlane W, Sherwin R, Coustan DR: The use of the insulin infusion pump in the management of pregnant diabetics. New England Perinatology Society, Waterville Valley, New Hampshire, 1981. 10. Carpenter MW, Coustan DR, Hobbins JC: Sequential fetal sonography in diabetic pregnancy and prediction of growth abnormality. Society for Gynecologic Investigation, St. Louis, 1981. 11. Ravin ND, Coustan DR, Gertner JM, Kliger AS, Broadus AE: Normal pregnancy is a state of physiologic absorptive hypercalcuria. American Society for Bone and Mineral Research, 1981. 12. Coustan DR, Berkowtiz RL, Hobbins JC: Engmaschige diabetes-kontrolle in der schwangerschaft. Extracta Gynaecologia Band 5, Heft 1, 44, 1981. 13. Rudolf MCJ, Tamborlane W, Sherwin R, Felig P, Genel M, Coustan DR: Is insulin pump treatment effective in managing the pregnant diabetic? Society for Pediatric Research, San Francisco, 1981. 14. Coustan DR, Ravin ND, Gertner JM, Kliger AS, Broadus AE: Normal pregnancy is a state of physiologic absorptive hypercalcuria. Society of Perinatal Obstetricians, San Antonio, 1982. 15. Coustan DR, Imarah J: Prophylactic insulin therapy prevents birth trauma in Class A diabetics. ACOG Annual Clinical Meeting, Dallas, 1982. 16. Coustan DR, Connolly LH: Significance of the falling insulin requirement in diabetic pregnancies. Society of Perinatal Obstetricians, San Antonio, 1983. 17. Widness JA, Coustan DR, Teramo KA, Clemons GK, Cavalieri RL, Oh W, Welch GP, Schwartz R: Correlation of the interpretation of fetal heart rate records with cord plasma erythropoietin levels. Society of Perinatal Obstetricians, San Antonio, 1984. 18. Coustan DR, Rudolf MCJ, Reece EA, Sockin S, Bates S, Holford T: Randomized trial of continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetics. American Diabetes Association, Las Vegas, 1984. 19. Canick JA, Brown LR, Coustan DR, Clifford NM, Kredenser J, Tulchinsky D: Sulfatase deficiency determined both in placenta and cultures of foreskin fibroblasts of a newborn. Seventh International Congress of Endocrinology, Quebec City, 1984. 20. Coustan DR, Widness J, Rotondo L, Oh W: Should the 50 gram one hour screening test for gestational diabetes be administered in the fasting or postprandial state? Tenth Annual New England Conference on Perinatal Research, Chatham Massachusetts, 1984. 21. Widness JA, Cowett RM, Coustan DR, Carpenter MW, and Oh W: Neonatal morbidities in infants of mothers with glucose intolerance in pregnancy. 2nd International Conference on Gestational Diabetes, American Diabetes Association, Chicago, 1984. 22. Coustan DR, Widness JA, Rotondo L, and Oh W: Should the 50 gram one-hour screening test for gestational diabetes be administered in the fasting or post-prandial state? Society of Perinatal Obstetricians, Las Vegas, 1985. 23. Reece EA, Coustan DR, Leahy P, Hayslett J, Holford T, Hobbins JC: Diabetic nephropathy: pregnancy performance and feto-maternal outcome. Society of Perinatal Obstetricians, Las Vegas, 1985.

Last updated 23 May 18 25

24. Coustan DR, Rudolf MCJ, Reece EA, Sherwin RS, Bates SE, and Tamborlane WV: A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. New England Perinatology Society, Woodstock, Vermont, 1985. 25. Coustan DR, Reece EA, Sherwin RS Rudolf, MCJ, Bates SE, Sockin SM, Holford T, and Tamborlane WV: A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. XIth World Congress of Gynecology and Obstetrics (FIGO), Berlin (West), 1985. 26. Young SB, Martelly PD, Greb LC, and Coustan DR: The effect of intraumbilical oxytocin on the duration of the third stage of labor. New England Perinatology Society, Woodstock, Vermont, 1986. 27. Coustan DR, Widness JA, Carpenter MW, Rotondo L, and Pratt DC: The breakfast tolerance test. New England Perinatology Society, Woodstock, Vermont, 1986. 28. Barcohana Y, Singer DB, Sheff M, and Coustan DR: The level of magnesium in CSF in the parturient receiving I.V. magnesium sulfate for the management of PIH. American College of Obstetricians and Gynecologists, 34th annual scientific meeting, New Orleans, 1986. 29. Reece EA, Coustan DR, Tuck S, Bates S, and Tamborlane W: Intensive treatment of IDDM in pregnancy: normalization of metabolic fuels despite hyperinsulinemia. American Diabetes Association, 46th annual meeting, Anaheim, 1986. 30. Carpenter MW, Sady S, Hoegsberg B, and Coustan DR: Fetal heart rate response to acute maternal voluntary exertion. Twelfth Annual New England Conference on Perinatal Research, Chatham Bars, Mass., Oct. 1986. 31. Hoegsberg B, Carpenter MW, Sady S, Haydon BB, Sady M, Thompson P, and Coustan DR: The effect of strenuous maternal exercise upon gross fetal body movements. Society of Perinatal Obstetricians, Orlando, 1987. 32. Carpenter MW, Sady S, Hoegsberg B, Haydon B, Sady M, Thompson P, and Coustan DR: Fetal heart rate response to acute maternal maximal voluntary exertion. Society of Perinatal Obstetricians, Orlando, 1987. 33. Hoegsberg B, Carpenter MW, Sady S, Thompson P, Coustan DR: Fetal movement before and after submaximal and maximal volitional maternal exercise. New England Perinatology Society, Woodstock, Vermont, 1987. 34. Carpenter M, Gruppuso, P, Widness J, Rotondo L, Malone M, and Coustan DR: Puerperal testing for gestational diabetes. American Diabetes Association, 47th Annual Meeting, Indianapolis, 1987. 35. Carr S, Coustan D, Martelly P, Brosco F, and Rotondo L: Reliability of capillary blood glucose determination by reflectance meter screening for gestational diabetes. Thirteenth Annual New England Conference of Perinatal Research, Chatham Bars Massachusetts, Oct 1987. 36. Coustan DR, Nelson C, Carpenter MW, Carr S, Rotondo L and Widness JA: Population -based study of relationship between maternal age and screening for gestational diabetes. Society of Perinatal Obstetricians, Las Vegas, 1988. 37. Carr SR, Coustan DR, Martelly P, Brosco F, and Rotondo L: Reliability of capillary glucose reflectance meters in screening for gestational diabetes. Society of Perinatal Obstetricians, Las Vegas, 1988. 38. Reece EA, Coustan DR, Tuck S, Sherwin R, Bates S, and Tamborlane W: Does intensive glycemic control in diabetic pregnancies result in normalization of other metabolic fuels? Society for Gynecologic Investigation, Baltimore, 1988. 39. Sady S, Carpenter M, Sady M, Haydon B, Cullinane E, Thompson P, and Coustan D: Cardiovascular response to exercise during pregnancy. American College of Sports Medicine, Dallas, 1988. 40. Carpenter M, Sady S, Sady M, Haydon B, Cullinane E, Thompson P, and Coustan D: VO2 Max prediction during cycle exercise in pregnancy. American College of Sports Medicine, Dallas, 1988. Last updated 23 May 18 26

41. Sady M, Haydon B, Sady S, Carpenter M, Coustan D, and Thompson P: Maximal exercise during pregnancy and postpartum. American College of Sports Medicine, Dallas, 1988. 42. Hoegsberg B, Gruppuso P and Coustan D: Fetal hyperinsulinemia in macrosomic infants of nondiabetic mothers. American Diabetes Association, 48th Annual Meeting, New Orleans, 1988. 43. Spirito A, Ruggiero L, Bond A, Bowen A, McGarvey S and Coustan D: The role of stress, coping, and social support in mediating the psychological status of women with gestational diabetes. Society of Behavioral Medicine, San Francisco, 1989. 44. Carpenter MW, Sady SP, Sady M, Haydon B, Coustan DR: Maternal exercise duration and intensity affect fetal heart rate. New England Perinatal Society, Manchester, Vermont, 1989. 45. Carpenter MW, Sady SP, Sady MA, Haydon B, Cullinane EM, Coustan DR, Thompson PD: Reduction of exercise capacity during pregnancy results from maternal weight gain. Society for Gynecologic Investigation, San Diego, 1989. 46. Carpenter M, Sady S, Haydon B, Sady M, Coustan D: Maternal exercise duration and intensity affect fetal heart rate. American College of Sports Medicine Annual Meeting, Baltimore, May 1989. 47. Cowett RM, Carpenter M, Maguire C, Sady M, Haydon B, Sady S, Dorcus B, Carr S, Kalhan S, Coustan D: Lactate oxidation during exercise in pregnancy. American Diabetes Association 49th Annual Scientific Meeting, Detroit, June 1989. 48. Ojomo EO and Coustan DR: Likelihood of respiratory distress syndrome (RDS) in term infants of diabetic mothers. Fifteenth annual New England Conference on Perinatal Research. Chatham, Massachusetts, October 1989. 49. Carr SR, Aronson M, Coustan DR: Survival rates of monoamniotic twins do not decrease after 30 weeks gestational age. Society of Perinatal Obstetricians, Houston, January 1990. 50. Ojomo EO and Coustan DR: Likelihood of immature lung profile in term infants of diabetic mothers. Society of Perinatal Obstetricians, Houston, January 1990. 51. Neiger R, Contag SA, Coustan DR: The resolution of preeclampsia-related thrombocytopenia. Society of Perinatal Obstetricians, Houston, January 1990. 52. Carpenter MW, Sady SP, Sady MA, Haydon BB, Coustan DR, Thompson PD: Effects of exercise training in midpregnancy: a randomized, controlled trial. Society for Gynecologic Investigation, St. Louis, March 1990. 53. Spirito A, Ruggiero L, Graff Low K, Coustan D, McGarvey S: Regimen adherence among pregnant women with diabetes. Society of Behavioral Medicine, Chicago, April 1990. 54. Coustan DR, Gruppuso PA, Carr SR, Carpenter MW, Riehl J, Tessier J, and Crocker M: Hyperinsulinemia in nonobese former gestational diabetic women. American Diabetes Association 50th Annual Scientific Meeting, Atlanta, June 1990. 55. Neiger R and Coustan DR: Degree of glucose tolerance test abnormality as a predictor of the requirement for insulin in gestational diabetes. American Diabetes Association 50th Annual Scientific Meeting, Atlanta, June 1990. 56. Neiger R and Coustan DR: The role of repeat GTT in the diagnosis of gestational diabetes. Society of Perinatal Obstetricians, San Francisco, January 1991. 57. Star J and Coustan DR: Does gestational diabetes represent preexisting glucose intolerance? Diabetes: Effects on Pregnancy and the Neonate, Satellite Symposium to 14th International Diabetes Federation Congress, Newport RI, June, 1991.

Last updated 23 May 18 27

58. Carpenter MW, Terry R, Carr S, Haydon B, Dorcas B, Thompson P, Coustan D, Cowett R: Endogenous glucose production mediates insulin resistance in normal but not gestational diabetic pregnancy. Society for Gynecologic Investigation, San Antonio, March 1992. 59. Star J, Canick J, Saller DN, Sung CJ, Tumber MB, Carpenter MW, Coustan DR: Elevated second trimester amniotic fluid glucose and insulin levels and the subsequent development of gestational diabetes. American Diabetes Association 52nd Annual Scientific Meeting, San Antonio, June 1992. 60. Coustan DR, Carpenter MW, O’Sullivan PS, Carr SR: Gestational diabetes: predictors of subsequent disordered glucose metabolism. American Gynecological and Obstetrical Society, Hot Springs, Virginia, September, 1992. 61. Yogev Y, Chen R, Hod M, Coustan D, Oats JJN, Metzger B, Lowe L, Dyer AR, Trimble , Hadden D, Persson B for the HAPO Study Cooperative Research Group: Associations with preeclampsia: lessons from the hyperglycemia and adverse pregnancy outcome (HAPO) study. Society for Maternal-Fetal Medicine 30th Annual Meeting, Chicago, February 2010. 62. Mendez-Figueroa H, Daley J, Lopes VV, Coustan DR: Comparing daily versus less frequent blood glucose monitoring in patients with mild gestational diabetes. Society for Maternal-Fetal Medicine 32nd Annual Meeting, Dallas, February 2012. 63. Starikov R, Coustan D, Chien E, Paglia M, Lopes V: Does hemoglobin A1c value determine risk of congenital heart disease in pre-gestational diabetes? Society for Maternal-Fetal Medicine 32nd Annual Meeting, Dallas, February 2012. Invited Presentations:

1. "Diabetes in Pregnancy" and "Gestational Diabetes." Grand Rounds, University of Louisville School of Medicine, Louisville, Kentucky, May 1981. 2. "Diabetes in Pregnancy: How Intensive Should We Be?" 29th Annual Postgraduate Course, American Diabetes Association, Orlando, Florida, January 1982. 3. "Diabetes in Pregnancy." Grand Rounds, Saginaw Cooperative Hospitals, Saginaw, Michigan, February 1982. 4. "Diabetes in Pregnancy." Martin L. Stone Society Biannual Lecture, Metropolitan Hospital, New York, May 1982. 5. "Prevention of Developmental Disabilities During Labor and Delivery." Symposium on Advances in Prevention of Developmental Disabilities. Brown University, Rhode Island Hospital, Providence, October 1982. 6. "Prospective Management Plans for the Gestational Diabetic." Symposium on Diabetes in Pregnancy, Baystate Medical Center, Springfield, Massachusetts, December 1982. 7. "Prescribing Medications in Pregnancy." Grand Rounds, Baystate Medical Center, Springfield, Massachusetts, December 1982. 8. "Risks and Benefits of Medications Given During Pregnancy." Symposium on "Womb Invaders." Michigan State University, East Lansing, Michigan, February 1983. 9. "Management of the Pregnant Overt Diabetic" and "Diagnosis and Management of the Gestational Diabetic." Symposium on Pregnancy and Diabetes Mellitus. St. Joseph's Hospital and Medical Center, Paterson, New Jersey, March 1983. 10. "Gestational Diabetes: Who to Screen, When to Screen, How to Screen, and What to do when Diagnosed." 3rd Annual Diabetes Symposium, Idaho Falls, Idaho, October 1983.

Last updated 23 May 18 28

11. "Pregnancy and Diabetes." 14th Annual Symposium of Connecticut Affiliate of American Diabetes Association, Hartford, Connecticut, November 1983. 12. "Gestational Diabetes." Grand Rounds at Mt. Sinai Medical Center, New York City, November 1983. 13. "Gestational diabetes: diagnosis and treatment." New Thoughts on Old Problems for the Practicing Obstetrician/Gynecologist, University of Connecticut Health Center, Farmington Connecticut, April 1984. 14. "The Use of Medications During Pregnancy" and "Overt Diabetes in Pregnancy." Obstetrical Review Session. St. Joseph Mercy Hospital, Pontiac, Michigan, May 1984. 15. "Diabetes and Pregnancy." Boston University Review Course in Obstetrics and Gynecology, Boston, May 1984. 16. "The physician as coordinator of the health care team." Symposium on the role of the health care team in the management of diabetic pregnancies. American Diabetes Association Council on Diabetes in Pregnancy, Las Vegas, 1984. 17. Visiting Professor in Obstetrics and Gynecology, Rush Medical School, Rush-Presbyterian-St. Luke's Medical Center, Chicago. Lectures on "Diabetes in Pregnancy" and "The Use of Medications in Pregnancy." February, 1985. 18. Visiting Professor in Pediatrics and in Obstetrics and Gynecology, University of Cincinnati College of Medicine. Lectures on "The Insulin Pump in Diabetic Pregnancy, "Gestational Diabetes, " and "The Use of Medications in Pregnancy." February, 1985. 19. "Diabetes in Pregnancy." Boston University Review Course In Obstetrics and Gynecology, Boston, March, 1985. 20. "Diabetes in Pregnancy." Semmelweiss-Waters OB/GYN Conference, Atlantic City, March, 1985. 21. Lectures: "Obstetrical Problems in the Pregnant Diabetic in the First Half of Pregnancy" and "Insulin and Gestational Diabetes": Conference on Diabetes in Pregnancy, University of Louisville, Louisville, Kentucky, June, 1985. 22. "The use of prophylactic insulin for gestational diabetes." Symposium on Diabetes and Pregnancy, XII International Diabetes Federation Congress, Seville, Spain, 1985. 23. "Pathophysiology of diabetic pregnancy" and "Gestational diabetes vs pregnancy in the diabetic." Diabetes in Pregnancy Symposium, American Diabetes Association, Ohio Affiliate, Cincinnati, October, 1985. 24. Visiting Professor, University of Wisconsin Medical School, Milwaukee Campus and Madison Campus. Lectures: "Diagnosis and Management of Gestational Diabetes," and "The Use of Medications During Pregnancy, " October, 1985. 25. "Diabetes in Pregnancy," Waltham-Weston Hospital and Medical Center, Waltham, Massachusetts, October, 1985. 26. "Managing the Pregnant Diabetic" and "Gestational Diabetes," Diabetes Update, Saginaw General Hospital, Saginaw, Michigan, November, 1985. 27. Visiting Professor, Tulane University School of Medicine. Lecture: "Diabetes in Pregnancy," November, 1985. 28. "Diabetes and Pregnancy," Perinatal Seminar, Mercy Hospital, Pittsburgh, December, 1985. 29. Visiting Professor, New York Hospital-Cornell Medical Center. Lecture: "The Use of Medications During Pregnancy," December, 1985. 30. "Diabetes in Pregnancy," Seminar at Diabetes Treatment Center, Atlanta, Georgia, December, 1985.

Last updated 23 May 18 29

31. "Gestational Diabetes," Maine Diabetes in Pregnancy Project, Portland, Maine, January, 1986. 32. "Diabetes in Pregnancy," Combined Obstetric-Pediatric Grand Rounds, St. Vincent's Medical Center, Worcester, Mass., February, 1985. 33. Visiting Professor, Northwestern University Medical School, Chicago. Lecture: "Gestational Diabetes," March 1986. 34. "Diabetes in Pregnancy," Boston University Review Course in Obstetrics and Gynecology, Boston, March, 1986. 35. "The Use of Prophylactic Insulin in Women with Gestational Diabetes," invited main speaker at First International Graz Symposium on Disturbances of Carbohydrate Metabolism During Pregnancy. Graz, Austria, April, 1986. 36. "The Use of Medications During Pregnancy," Guest Lecturer at Geburtshilflich-Gynakologische Universitatklinik, Graz, Austria, April 1986. 37. "Gestational Diabetes," Update in High Risk Obstetrics, St. Francis Hospital, Milwaukee, Wisconsin, April, 1986. 38. "Gestational Diabetes," "PROM," "Overt Diabetes," and "Delivery of the Very Low Birthweight Infant," Eleventh Annual Perinatal Seminar, Rogue Valley Medical Center, Ashland, Oregon, July, 1986. 39. "Gestational Diabetes: Detection and Management," Seminar of Maine Diabetes in Pregnancy Project, New Harbor, Maine, October 1986. 40. Visiting Professor at Wilhelm Pieck University Frauenklinik, Rostock, German Democratic Republic, 9-24 Oct 1986. Lectures on "The Use of Medications During Pregnancy" and "Fetal Monitoring." 41. "The Use of Medications During Pregnancy," Frauneklinik of Krankenhaus Kaulsdorf, Berlin, German Democratic Republic, 18 October 1986. 42. "Management of Overt Diabetes in Pregnancy" and "The Use of the Insulin Pump in Diabetic Pregnancy," Third Annual Diabetes Update 86, Saginaw General Hospital, Saginaw, Michigan, November 1986. 43. "Gestational Diabetes and Perinatal Outcome." The Infant of the Diabetic Mother, 93rd Ross Conference on Pediatric Research, Carefree, Arizona, November 1986. 44. "Overt Diabetes in Pregnancy," "Gestational Diabetes," and "The Use of Medications During Pregnancy." Boston University Course in Obstetrics and Gynecology, Orlando, 27-29 Dec 1986. 45. "Gestational Diabetes." Obstetrical and Gynecological Grand Rounds, Mount Sinai Hospital, Hartford, Connecticut, 9 January 87. 46. "Diabetes, Pregnancy and Exercise." American Physical Therapy Association 1987 Combined Sections Meeting, Atlanta, 14 February 1987. 47. "The Pregnant Diabetic: Initial evaluation, stabilization, and control," and "Selection of optimal delivery date." Seminar of the Baystate Medical Center, Springfield, Mass., 11 March 1987. 48. "Detection and treatment of gestational diabetes," Obstetrics and Gynecology Grand Rounds, University of Connecticut, New Britain, Conn., 18 March 1987. 49. "Diabetes in Pregnancy," Boston University Review Course and Update in Obstetrics and Gynecology, Boston, 1 April 1987. 50. "Diagnosis and treatment of gestational diabetes," Premier Colloque de Perinatologie, Hospital Cantonal Universitaire de Geneve, Geneva, Switzerland, 10 April 1987.

Last updated 23 May 18 30

51. "Gestational Diabetes" and "Medications in Pregnancy," Palm Beach Society of Obstetrics and Gynecology, West Palm Beach, Florida, 20 April 87. 52. "Gestational Diabetes: Diagnosis and Management," Perinatal Symposium of Northridge Hospital Medical Center, Northridge, California, 5 June 87. 53. "Diabetes in Pregnancy," Health Care: Is It A Right? Sponsored by Georgia Department of Human Resources, Savannah, Georgia, 28 September 87. 54. "Gestational Diabetes," Health Care Issues for Women With Diabetes. Michigan Diabetes Research and Training Center and Michigan Affiliate of American Diabetes Association, Ann Arbor, Michigan, October 1987. 55. "Gestational Diabetes," Obstetrics and Gynecology Grand Rounds. University of Michigan Medical Center, Ann Arbor, Michigan, October, 1987. 56. "Labor and Delivery for Patients with Diabetes," Seminar of Maine Diabetes in Pregnancy Project, New Harbor, Maine, October, 1987. 57. "Universal vs Selected Screening for Gestational Diabetes" and "Options for Macrosomia Prevention in Gestational Diabetes." Critical Issues in Diabetes in Pregnancy, New York, Albert Einstein College of Medicine, November, 1987. 58. "The Use of Medications During Pregnancy," "Premature Rupture of the Membranes and its Management," and "Gestational Diabetes: Diagnosis and Management." Current Topics in Gynecology and High Risk Obstetrics, Orlando, Florida, Boston University School of Medicine, December, 1987. 59. "Use and Abuse of Medications During Pregnancy." The First Thirty Minutes: the Boston City Hospital Approach to Medical and Pediatric Emergencies. Orlando, Florida, December, 1987. 60. "Diagnosis and Management of Gestational Diabetes," Obstetrics and Gynecology Grand Rounds, The Allentown Hospital, Allentown, Pennsylvania, 22 February 1988. 61. "Management of the Pregnant Woman with Diabetes," Internal Medicine Grand Rounds, Lehigh Valley Medical Center, Allentown Pennsylvania, 22 Feb. 88. 62. "The Identification, Management, and Importance of Gestational Diabetes Mellitus," 14th Annual Conference on Perinatal Medicine, Iowa Great Plains Organization, Des Moines, April 1988. 63. "Gestational Diabetes" and "Complications of Diabetes: Pre and Postpartum," Conference on Successful Management of Diabetes and Pregnancy, San Diego Gynecological Society and American Diabetes Association, San Diego Chapter, San Diego, April 1988. 64. "Diagnosis and Management of Gestational Diabetes," Conference on Diabetes and Pregnancy, American Diabetes Association, New York Downstate Affiliate, New York City, April 1988. 65. "Diagnosis of Gestational Diabetes" and "Management of Diabetes in Pregnancy," Third Annual Cleveland Conference on Perinatal Medicine, Cleveland, May 1988. 66. "Detection of Gestational Diabetes" and "Obstetrical Management of the Pregnant Diabetic," Diabetes and Pregnancy Symposium, American Diabetes Association Capital Area Chapter, Austin, Texas, May 1988. 67. "Gestational Diabetes" and "Overt Diabetes in Pregnancy," Grand Rounds at William Beaumont Hospital, Royal Oak, Michigan, Sept 1988. 68. "Strategies in the Use of Medication in Pregnancy," Keynote address at Annual Meeting of Western Massachusetts Perinatal Association, Hancock Massachusetts, Sept 1988. 69. "Gestational Diabetes: the Science Base" and "Community Studies: Diabetes and Pregnancy," Third National Conference on Chronic Disease Control and Prevention, sponsored by CDC, Denver, October 1988. Last updated 23 May 18 31

70. "Maternal and Obstetric Complications During Diabetic Pregnancy," Fifth Annual Diabetes Update '88, Saginaw, Michigan, November 1988. 71. "Diabetes in Pregnancy," Obstetric and Gynecologic Grand Rounds, Cornell University-New York Hospital, November 1988. 72. "Definitions in Diabetes in Pregnancy: The North American Viewpoint" and plenary session moderator, Satellite Symposium on Diabetes in Pregnancy, Thirteenth Annual International Diabetes Federation Congress, Auckland, New Zealand, November 1988. 73. "Management of Diabetes in Pregnancy," American Diabetes Association Montgomery County Chapter, Washington Area Affiliate, Bethesda, December 1988. 74. "Medical and Obstetric Complications in Women With Diabetes" and "The Use of Medications During Pregnancy," Grand Rounds at Hutzel Hospital, Wayne State University School of Medicine, December 1988. 75. "Diabetes in Pregnancy, 1989" and "Prescribing for the Pregnant Patient - Hazards and Dilemmas," Boston University School of Medicine Review Course and Update in Obstetrics and Gynecology, Boston, March 1989. 76. "Screening for Gestational Diabetes" and "Food Additives and Pregnancy," Annual Semmelweiss-Waters Obstetrical and Gynecological Conference, University of Medicine and Dentistry of New Jersey, Atlantic City, April 1989. 77. "Medical Complications of Diabetes During Pregnancy," Rachmiel Levine Visiting Professor Lecture, Department of Medicine, New York Medical College/Westchester County Medical Center, Valhalla New York, April 1989. 78. "Strategies for Insulin Therapy in Gestational Diabetes," Clinical Seminar at American College of Obstetricians and Gynecologists Annual Clinical Meeting, Atlanta, May 1989. 79. "Gestational Diabetes," Grand Rounds at Baystate Medical Center, Springfield, Massachusetts, September 1989. 80. "Update in Management of Diabetes in Pregnancy" and "Diabetic Screening in Pregnancy," The Challenge of Perinatal Care in the Nineties, Allentown Hospital - Lehigh Valley Hospital Center, Allentown Pennsylvania, September 1989. 81. "Diabetes in Pregnancy," Annual Seminar on Medical Complications in Pregnancy, Henrico Doctors' Hospital, Richmond, Virginia, October 1989. 82. State of the Art Lecture: "Investigations into Testing for Gestational Diabetes," Fifteenth Annual New England Conference on Perinatal Research, Chatham, Massachusetts, October 1989. 83. "Medical Complications in Diabetic Pregnancy," Research and Therapeutic Issues in Diabetes: An International Conference, University of Virginia, Charlottesville Virginia, October 1989. 84. "Insulin Treatment of Gestational Diabetes" and Session Chairman, Second International Symposium on Diabetes and Pregnancy: Aspects of Current Research Relevant to Clinical Practice, Fiuggi, Italy, October 1989. 85. "Management of Gestational Diabetes," Visiting Professor at Policlinico Universitario, Universita Degli Studi di Messina, Messina, Italy, October 1989. 86. "The Use of Medications During Pregnancy," Obstetrical and Gynecological Grand Rounds at Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, November 1989. 87. "Diagnosis and Management of Gestational Diabetes," Pittsburgh Ob/Gyn Society, Pittsburgh, Pennsylvania, November 1989. Last updated 23 May 18 32

88. "Management of Overt Diabetes During Pregnancy," Obstetrical and Gynecological Grand Rounds, Magee-Women's Hospital, Pittsburgh, Pennsylvania, November 1989. 89. "Gestational diabetes," Yale-New Haven Medical Center, December 1989. 90. "Update on gestational diabetes," Grand Rounds at Mt. Sinai Medical Center, New York City, January 1990. 91. "Gestational diabetes: screening criteria and management approaches," 37th Annual Postgraduate Course of American Diabetes Association, Orlando, January 1990. 92. "Diabetes in Pregnancy," Anesthesiology and Critical Care Grand Rounds, Beth Israel Hospital, Boston, January 1990. 93. "Gestational Diabetes - Does It Exist?" and "Diabetic Ketoacidosis in Pregnancy," First Annual Leonard Visiting Professor, University of Wisconsin Department of Obstetrics and Gynecology, Madison Wisconsin, January 1990. 94. "Gestational Diabetes," Grand Rounds of Department of Obstetrics and Gynecology, Tufts University Medical School, St. Margaret's Hospital, Boston, February 1990. 95. "Medical Complications in Diabetic Pregnancy," Contemporary Issues in Maternal-Fetal Medicine, University of Texas Health Sciences Center, San Antonio, April 1990. 96. "Gestational Diabetes: Does It Exist, and If So, What Shall We Do About It?" Lincoln Obstetrical and Gynecological Society, Lincoln, Nebraska, May 1990. 97. "Workshop on Diabetes in Pregnancy," Lincoln General Hospital, Lincoln, Nebraska, May 1990. 98. "Diagnosis and Management of Gestational Diabetes," Clinical Seminar at 38th Annual Clinical Meeting, American College of Obstetricians and Gynecologists, San Francisco, May 1990. 99. "Management of the Patient With Gestational Diabetes," Current Issues in Gynecology and Obstetrics, Albany Medical College, June 1990. 100. Visiting Professor, Mayo Clinic, Rochester Minnesota, September 1990. 101. "Gestational Diabetes: Does it Exist?" Grand Rounds, Boston City Hospital, Boston University School of Medicine, October 1990. 102. "Gestational Diabetes: Does it Exist?" Fifth Annual Diabetes Center Clinical Symposium, San Antonio, October 1990. 103. "The Diagnosis of GDM: What Are Our Objectives?" Lecture and session chairman, 3rd International Workshop Conference on Gestational Diabetes Mellitus. Chicago, November 1990. 104. "Does Gestational Diabetes Exist,?" "Advances in Management of Diabetes in Pregnancy," and session chairman, International Conference on Advances in Obstetrics and Gynecology, Taipei, Taiwan, Republic of China, December 1990. 105. "Management of Gestational Diabetes," Satellite Symposium of the International Conference on Advances in Obstetrics and Gynecology, Kowloon, Hong Kong, December 1990. 106. “Does gestational diabetes exist? If so, what should be done about it?” Second Colloque de Perinatologie, Hôpital Cantonal Universitaire de Genève, Geneva Switzerland, March 1991. 107. Program Chair, Diabetes: Effects on Pregnancy and the Neonate, Satellite Symposium to 14th International Diabetes Federation Congress, Newport RI, June, 1991. 108. “Gestational diabetes: does it exist?” and “Gestational diabetes: morbidity prevention.” Current Concepts and Controversies in Perinatal Care. University of New Mexico, Albuquerque, September 1991.

Last updated 23 May 18 33

109. Moderator of session on Gestational Diabetes; 23rd Annual Meeting of the Diabetic Pregnancy Study Group (Europe). Wexford, Ireland, September 1991. 110. “Does gestational diabetes exist?” and “If so, what should we do about it.” Seventh annual conference of Japan Study Group on Diabetes and Pregnancy. Fukuoka, Japan. 30 November, 1991. 111. “Diagnosis and Management of Gestational Diabetes.” American Diabetes Association 39th Annual Advanced Postgraduate Course. Orlando, January 1992. 112. "Does gestational diabetes exist?” Plenary lecture at Annual Scientific Meeting of Royal Australian College of Obstetricians and Gynecologists, Melbourne, April 1992. 113. "Medical complications in diabetic pregnancy” Plenary lecture at annual meeting of Australasian Diabetes in Pregnancy Society, Melbourne, April 1992. 114. "Screening and testing for gestational diabetes,” Plenary Lecture at 52nd Annual Scientific Meeting of American Diabetes Association, San Antonio, June 1992. 115. "Screening for gestational diabetes,” Keynote Lecture at 24th Annual Meeting of Diabetic Pregnancy Study Group of the European Association for the Study of Diabetes, Silkeborg, Denmark, Sept 1992. 116. "Does gestational diabetes exist?” Guest lecture at Reading Hospital Medical Center, Reading Pennsylvania, Sept 1992. 117. "Does gestational diabetes exist?” Obstetric and Gynecologic Grand Rounds, Yale Medical School, New Haven, Conn, Sept 1992. 118. "Screening and diagnosis of gestational diabetes.” Plenary lecture and session moderator at Second International Graz Symposium on Gestational Diabetes. Graz, Austria, Oct 1992. 119. "Does Gestational Diabetes Exist?” and "Management of Overt Diabetes in Pregnancy” Combined Internal Medicine/Obstetric Grand Rounds, Memorial Medical Center, Savannah, Georgia, Oct 1992. 120. "Gestational Diabetes” Plenary lecture at New England Obstetrical and Gynecological Society, Boston, Mass, Nov 1992. 121. "Vascular Complications of Diabetes in Pregnancy” Diabetes Clinical Conference at Yale New Haven Medical Center, New Haven, Conn, Nov 1992. 122. "Obstetrical complications of gestational diabetes mellitus” International Workshop on Adverse Perinatal Outcomes of Gestational Diabetes sponsored by NICHD and NIDDK, Bethesda, December 1992. 123. "Controversies regarding diagnosis of gestational diabetes,” "Treatment of gestational diabetes,” and "Obstetrical management of diabetic women.” Management of Diabetes and Pregnancy: 1993, Symposia Medicus. Cancun, Mexico, January 1993. 124. "Does gestational diabetes exist? If so, how should we look for it?” San Diego Gynecologic Society. San Diego, Calif. February, 1993. 125. "Management of Gestational Diabetes” Visiting Professor, University of California San Diego, February, 1993. 126. "Controversies regarding diagnosis of gestational diabetes,” "Treatment of gestational diabetes,” and "Obstetrical management of diabetic women.” Management of Diabetes and Pregnancy: 1993, Symposia Medicus. Honolulu, Hawaii, March 1993. 127. "Gestational Diabetes” Royal College of Physicians of Ireland Institute of Obstetricians and Gynaecologists, Dublin, March 1993. 128. "Management of abnormal glucose metabolism in pregnancy” Symposium on Abnormal Glucose Metabolism in Pregnancy. National Maternity Hospital, Dublin, Ireland, March, 1993. Last updated 23 May 18 34

129. "Screening and diagnosis of gestational diabetes.” Clinical Seminar, American College of Obstetricians and Gynecologists Annual Clinical Meeting, Washington, DC, May 1993. 130. "Diabetes in Pregnancy” Educational program at Charlton Memorial Hospital, Fall River, Massachusetts, May 1993. 131. "Management of Gestational Diabetes” and "Contraception for the Diabetic Patient” Premieres Journees Internationales de Pratique Obstetricale, FIGO, Paris, France, May 1993. 132. "Gestational diabetes,” "Pre-existing diabetes in pregnancy,” "Potpourri of Medical Complications,” and "Use of medications during pregnancy.” Second Annual Ob-Gyn Seminar, Anchorage, Alaska, July 1993. 133. "Premature rupture of membranes,” Gestational diabetes,” "Pre-existing diabetes,” "Using medications in pregnancy.” Eighteenth Annual Perinatal Seminar, Rogue Valley Medical Center, Ashland, Oregon, July 1993. 134. "Does gestational diabetes exist?” Obstetrics and Gynecology Grand Rounds, Beth Israel Hospital, Boston. Sept 1993. 135. "Planning for pregnancy in the woman with diabetes: a golden opportunity.” Annual Scientific Meeting of the Kentucky Medical Association. Louisville, Sept 93. 136. "Management of Gestational Diabetes” Visiting Professor at University of Louisville Dept of ObGyn, Louisville, Kentucky, Sept 1993. 137. "Gestational Diabetes.” American College of Physicians Course on Medical Disorders During Pregnancy (KA Rosene and DR Coustan, co-Directors). Newport, RI October 1993. 138. "Does gestational diabetes exist?” Grand Rounds, Department of Ob/Gyn. Brigham & Women’s Hospital, Feb 1994. 139. "The Future of Academic Maternal-Fetal Medicine” Society of Perinatal Obstetricians Fellows’ Retreat, San Antonio, April 1994. 140. "Does Gestational Diabetes Exist?” Columbus Obstetric Society, Columbus Ohio April 1994. 141. "Incompetent cervix.” Grand Rounds, Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus Ohio, April 1994. 142. "Diagnosis and Management of Gestational Diabetes.” Postgraduate course at American College of Obstetricians and Gynecologists Annual Clinical Meeting, Orlando Florida, May 1994. 143. "Does Gestational Diabetes Exist?” and "The Use and Abuse of Medications in Pregnancy” Seventh Annual Rochester Conference in Perinatal Medicine, University of Rochester Dept of Obstetrics and Gynecology, Rochester NY, May 1994. 144. "Gestational Diabetes.” Seventeenth Annual Seminar on Current Concepts in Fetal and Neonatal Care, Newport RI, May 1994. 145. "Impact of diagnostic criteria on incidence of gestational diabetes.” Council on Diabetes in Pregnancy, American Diabetes Association 54th Annual Scientific Sessions, New Orleans, Louisiana, June 1994. 146. "Incompetent Cervix.” Grand Rounds, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven Connecticut, June 1994. 147. "Reflections of Yale.” Speech at Residents Research Day, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven Connecticut, June 1994. 148. "The Incompetent Cervix,” Grand Rounds at Northshore University Medical Center in Manhasset, Long Island, September 1994.

Last updated 23 May 18 35

149. "Diagnosis and Management of Gestational Diabetes,” invited lecture at XIV World Congress of Gynecology and Obstetrics (FIGO), Montreal, September 1994. 150. "Cervical Incompetence” and "Medical Complications of Diabetic Pregnancy.” Invited lectures at Updates in Obstetrics and Gynecology, Mount Sinai School of Medicine and Hadassah University Hospital, Jerusalem, October 1994. 151. "Issues in the Treatment of Diabetes.” Invited lecture at Scientific Committee Meeting on Diabetes. San Francisco, October 1994. 152. "Gestational Diabetes.” The Brown Biomedical Collegium Providence, October 1994. 153. "Does Gestational Diabetes Exist?” Grand Rounds, Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, November 1994. 154. "Incompetent Cervix” and "Prescribing During Pregnancy.” Grand Rounds at Temple University Medical Center, Philadelphia, November 1994. 155. "Incompetent Cervix.” Grand Rounds at University of Medicine and Dentistry of New Jersey, Department of Obstetrics and Gynecology, Newark, November 1994. 156. "Gestational Diabetes,” "Diabetic Ketoacidosis in Pregnancy,” and "Pre-existing Diabetes in Pregnancy.” Invited speaker at XXIII Encontro Anual do Instituto Estadual de Diabetes e Endocrinologia, Rio de Janeiro, Brazil, December 1994. 157. Course Coordinator, Post Graduate Course on Medical Complications of Pregnancy, 15th Annual Meeting of Society of Perinatal Obstetricians. Lecture "Medically Complicated Diabetes in Pregnancy.” Atlanta, January 1995. 158. Moderator, Concurrent Abstract Session on Medical Complications, 15th Annual Meeting of Society of Perinatal Obstetricians, Atlanta, January 1995. 159. "Medical Management of Diabetes in Pregnancy.” Invited speaker at Annual Postgraduate Course, University of the West Indies and the American Diabetes Association, Ocho Rios, Jamaica, February 1995. 160. "Reproductive Issues in the Diabetic Female.” Diagnosis and Treatment of Genitourinary Disorders in Diabetes, Sponsored by American Diabetes Association and NIDDK, San Francisco, March 1995. 161. "Gestational Diabetes: Do We Have To Create A New Diagnostic test?” and "Diabetic Ketoacidosis in Pregnancy.” 2nd International Symposium on Diabetes and Pregnancy. Jerusalem, March 1995. 162. "Gestational diabetes.” Grand Rounds at York Hospital, York, Maine, April 1995. 163. Diagnosis and management of gestational diabetes. Clinical Seminar at Annual Clinical Meeting of American College of Obstetricians and Gynecologists, San Francisco, May 1995. 164. Advances in the diagnosis and management of gestational diabetes. National Maternal Nutrition Intensive Course Sponsored by US Bureau of MCH and University of Minnesota, Minneapolis, July 1995. 165. "Gestational diabetes.” Grand Rounds at Thayer Hospital, Waterville, Maine, July 1995. 166. "Gestational diabetes: does it exist?” and "Prescribing during pregnancy.” Advances in Clinical Perinatal Medicine, SUNY at Syracuse, September 1995. 167. "The Future of Maternal-Fetal Medicine” Society of Perinatal Obstetricians Retreat for MFM Fellows, Orlando, Florida, October 1995. 168. "The Future of Obstetrics and Gynecology,” American College of Obstetricians and Gynecologists District I Junior Fellows Meeting, Newport, RI, October 1995.

Last updated 23 May 18 36

169. "Medically complicated diabetes in pregnancy,” "Diagnosis of gestational diabetes,” "Management of gestational diabetes” and session moderator. International Symposium on Diabetes in Pregnancy in Arabian Gulf Countries, sponsored by King Fahad National Guard Hospital, Riyadh, Saudi Arabia, November 1995. 170. "Diabetic nephropathy, retinopathy, and DKA in pregnancy.” Medical Disorders During Pregnancy, sponsored by American College of Physicians, Breckenridge, Colorado, January 1996. 171. "Gestational diabetes: does it exist?” and "The incompetent cervix: can’t we think of a better name?” 27th Annual Tucson Seminar in Obstetrics and Gynecology. The University of Arizona College of Medicine. Tucson, February 1996. 172. "Cervical Incompetence” and "Prescribing During Pregnancy.” Visiting Professor at the University of Massachusetts Medical Center, Worcester, January 1996. 173. "Diabetes in Pregnancy.” Dominican Society of Perinatal Medicine, Dominican Society of Obstetrics and Gynecology, Santo Domingo, Dominican Republic, February 1996. 174. "Contraception for the woman with diabetes” and "Epidemiology and diagnosis of gestational diabetes.” 2nd International Conference and Postgraduate Course, jointly sponsored by the University of the West Indies and the American Diabetes Association. Ocho Rios, Jamaica, February 1996. 175. "An update in gestational diabetes” Obstetrics and Gynecology Grand Rounds at Hartford Hospital, Hartford, February 1996. 176. "Gestational diabetes,” Endocrine Grand Rounds, Baylor University, Houston, Texas, March 1996. 177. "The management of medically complicated diabetes in pregnancy,” Ob/Gyn Grand Rounds, Downstate Medical Center, State University of New York at Brooklyn, April 1996. 178. "The making of an ACOG Technical Bulletin,” Obstetrical Society of Philadelphia, April 1996. 179. "Update on gestational diabetes,” Ob/Gyn Grand Rounds, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, April 1996. 180. “Gestational diabetes: diagnosis and management,” American College of Obstetricians and Gynecologists, 44th Annual Clinical Meeting, Denver, April 1996. 181. Profesor Visitante, Universidad Nacional Mayor de San Marcos, Lima, Peru. Eight lectures presented. July, 1996. 182. Chair and Consultant, 28th Annual Meeting of the Diabetic Pregnancy Study Group of the European Association for the Study of Diabetes, Klampenborg, Denmark, September 1996. 183. "Gestational diabetes," plenary lecture at 50th Anniversary of the Copenhagen Center for Diabetes and Pregnancy, Copenhagen, September 1996. 184. Course Director, Postgraduate Course on Medical Complications of Pregnancy, lectures on "Management of diabetes in pregnancy" and "Prescribing during pregnancy." 3rd World Congress of Perinatal Medicine of the World Association of Perinatal Medicine, San Francisco, October 1996. 185. "Prediabetes during and after pregnancy," lecture at Managing Diabetes in the Real World, San Jose, California, November 1996. 186. "Management of Type 1 diabetes in pregnancy," 13th Annual Diabetes Update of Saginaw General Hospital, Saginaw Michigan, November 1996. 187. "Does gestational diabetes exist" and "Cervical incompetence," Autumn in New York Symposium of the Albert Einstein College of Medicine, New York City, November 1996.

Last updated 23 May 18 37

188. “Does gestational diabetes exist?,” “Management of gestational diabetes,” and “Prescribing during pregnancy.” Annual Meeting of the Washington State Obstetrical Association, Seattle, December 1997. 189. "Management of gestational diabetes." Diabetes Mellitus Symposium of American Association of Clinical Endocrinologists. Keystone, Colorado, February 1997. 190. Coustan DR and Carpenter MW: The diagnosis of gestational diabetes. Presented at 4th International Workshop-Conference on Gestational Diabetes Mellitus, Chicago, IL March 13-16, 1997. 191. Pfizer Visiting Professor at Duke University, Department of Obstetrics and Gynecology, Durham, North Carolina, April 1997. 192. "Gestational Diabetes: Does It Exist?" and "Management of Pregnancy in Women With Pre-existing Diabetes." Decimocuarta Reunion Anual, Instituto Nacional de Perinatologia, Mexico City, Mexico, April 1997. 193. "Diagnosis and Management of Gestational Diabetes," American College of Obstetricians and Gynecologists Annual Clinical Meeting, Las Vegas, April 1997. 194. "Does Gestational Diabetes Exist?" Grand Rounds, Tufts New England Medical Center, Boston, May 1997. 195. "Incompetent Cervix," Grand Rounds, Massachusetts General Hospital, Boston, June 1997. 196. "Does Gestational Diabetes Exist? Diagnosis and Treatment." Principal Speaker, Annual General Assembly of the Swiss Society of Obstetrics and Gynecology. Lugano, Switzerland, June 1997. 197. "The Norbert Freinkel Memorial Lecture: Gestational Diabetes: 33 years without consensus." 16th International Diabetes Federation Congress, Helsinki, Finland, July 1997. 198. "The Future of Maternal-Fetal Medicine” Society of Perinatal Obstetricians 3rd Retreat for MFM Fellows, San Antonio, Texas, October 1997. 199. "Management of Gestational Diabetes: New Recommendations" Second Annual Roy H. Petrie Memorial Symposium, Saint Louis University, St. Louis, Missouri, December 1997. 200. "Update on Gestational Diabetes" American Diabetes Association 45th Annual Advanced Postgraduate Course, San Francisco, January 1998. 201. "Gestational diabetes: Screening, diagnosis and management in 1998." Masters’ Series Roundtable, 18th annual meeting of the Society of Perinatal Obstetricians, Miami, February 1998. 202. "The Future of Maternal-Fetal Medicine" Banquet speech at the 18th annual meeting of the Society of Perinatal Obstetricians, Miami, February 1998. 203. "Does Gestational Diabetes Exist?" Grand Rounds at University of Southern California, Los Angeles County Women’s Hospital, Los Angeles, February 1998. 204. "Cervical cerclage: indications, techniques and management," "Prescribing during pregnancy," "Gestational diabetes," and "Pre-existing diabetes: counseling and management of the medically complicated pregnancy." Perinatal Medicine Course sponsored by USC School of Medicine, Maui, Hawaii, February 1998. 205. "Gestational Diabetes: Does It Exist?" Ob/Gyn Grand Rounds at Memorial Hospital Southwest, Houston Texas, March 1998. 206. "Gestational Diabetes: Does It Exist?" Ob/Gyn Grand Rounds at University of Texas Health Sciences Center at Houston, Houston Texas, March 1998. 207. "Prescribing During Pregnancy." Houston Gynecologic and Obstetric Society, Houston Texas, March 1998. Last updated 23 May 18 38

208. "Gestational Diabetes: Does It Exist?" Ob/Gyn Grand Rounds at Baylor College of Medicine, Houston Texas, March 1998. 209. "Prescribing in Pregnancy" Grand Rounds at Reading Hospital, Reading, Pennsylvania, April 1998. 210. Visiting Professor, East Carolina University, Greenville, North Carolina. "Prescribing During Pregnancy" and "Does Gestational Diabetes Exist?" April 1998. 211. Course Director, Series 060 Postgraduate Course "Management of Medical Conditions in Pregnancy." American College of Obstetricians and Gynecologists 46th Annual Clinical Meeting, New Orleans, May 1998. 212. Pfizer Visiting Professor at the University of New Mexico, Albuquerque, May 1998. 213. "Prescribing in Pregnancy." Current Concepts in Fetal and Neonatal Care: 21st Annual Seminar. Newport, RI May 1998. 214. Moderator, Council Discussion on Recommendations of the Fourth International Workshop-Conference on Gestational Diabetes. American Diabetes Association 58th Annual Scientific Session, Chicago, June 1998. 215. "Update on Diabetes" and "Debate: Gestational Diabetes: Does It Exist?" American College of Physicians Course on Medical Problems of Pregnancy. Toronto, June 1998. 216. Invited speaker, XVI Jornadas de Obstetrica y Ginecologia, Sociedad de Obstetrica Y Ginecologia de Buenos Aires, Buenos Aires Argentina, July 1998. 217. "Gestational Diabetes," Invited Speaker at Tufts Roundtable on Nutrition for Women in Their Child- Bearing Years. Boston, July 1998. 218. Moderator, Session on Obstetrical and Gynaecologic Considerations, and member of the Organizing Committee, First International Colloquium of the Diabetes in Pregnancy Study Groups. Cairns, Queensland, Australia, August 1998. 219. Gestational Diabetes: Diagnosis and Management." Grand Rounds at Lenox Hill Hospital, New York, NY. September 1998. 220. Discussant, paper by Dr. Patrick Catalano: Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. American Gynecological and Obstetrical Society, Hot Springs, Virginia, September 1998. 221. "Gestational Diabetes." Grand Rounds, Department of Obstetrics and Gynecology, Maine Medical Center, Portland, October 1998. 222. "Gestational diabetes: does it exist?" and "Management of complicated diabetic pregnancy." Update in Obstetrics and Gynecology. Winthrop-University Hospital, Mineola, LI, NY. October 1998. 223. "Gestational Diabetes" Clinical Endocrinology Update: 1998. The Endocrine Society. Boston, MA, November 1998. 224. "Screening and diagnosis of gestational diabetes: does it exist?" National Perinatal Association Annual Meeting. Providence, RI, November 1998. 225. "Gestational Diabetes" Endocrine Grand Rounds, Boston City Hospital, Boston University School of Medicine, January 1999. 226. Moderator, Fellows’ Plenary Session, Society of Maternal Fetal Medicine, 19th Annual Scientific Meeting, San Francisco, January 1999. 227. “Cervical Cerclage,” “Prescribing During Pregnancy,” and “Gestational Diabetes,” High Risk Obstetrics Postgraduate Course, Society of Maternal-Fetal Medicine, Phoenix, February 1999.

Last updated 23 May 18 39

228. “Cervical Cerclage,” “Prescribing During Pregnancy,” “Gestational Diabetes,” and “Pre-Existing Diabetes,” 25th Annual Vail Obstetrics and Gynecology Conference, University of Colorado. February 1999. 229. Moderator, Clinical Perinatology I, 46th Annual Meeting of the Society for Gynecologic Investigation, Atlanta, March 1999. 230. “Gestational Diabetes,” “Prescribing in Pregnancy,” Visiting Professor, Department of Obstetrics and Gynecology, Delaware Medical Center, Christiana Hospital, March 1999. 231. “Prescribing in Pregnancy,” Ob/Gyn Grand Rounds, Massachusetts General Hospital, Boston, April 1999. 232. Moderator, session on “The Preconceptional Challenge,” Second Annual Meeting of the Diabetes in Pregnancy Study Group of North America, Cincinnati, Ohio, May 1999. 233. Visiting Professor at St. Francis Hospital and Medical Center, Hartford, Connecticut, 1999 Resident Research Day. Topic: “Diabetes in Pregnancy,” May 1999. 234. Postgraduate Course Director, Management of Medical Conditions In Pregnancy, American College of Obstetricians and Gynecologists 47th Annual Clinical Meeting in Philadelphia, Pennsylvania, May 1999. 235. “Diabetes in Pregnancy,” “Infections in Obstetrics and Gynecology,” and “Prescribing Medication: What is Safe During Pregnancy.” ACOG Update in Obstetrics and Gynecology, postgraduate course for Mexican Ob/Gyns, Mexico City and Morelia, Mexico, September 1999. 236. “Cervical Cerclage,” “Prescribing During Pregnancy,” and “Gestational Diabetes,” High Risk Obstetrics Postgraduate Course, Society of Maternal-Fetal Medicine, Washington DC, October 1999. 237. “Nutritional Management of Gestational Diabetes” American Dietetic Association 82nd Annual Meeting, Atlanta, October 1999. 238. “Gestational Diabetes: Is it a clinical entity? Should we screen?” First Congress on Controversies in Obstetrics, Gynecology & Infertility. Prague, Czech Republic, October 1999. 239. “Planning for and managing pregnancy in the patient with diabetes.” 3rd Annual Diabetes Conference Memorial Hospital, Colorado Springs, Colorado, December 1999. 240. “Screening and management of gestational diabetes mellitus.” Greater Fall River Physician CME Program, Fall River, Massachusetts, December 1999. 241. “Prescribing in pregnancy.” Greater Hartford Ob/Gyn Society, Hartford Connecticut, January 2000. 242. “Gestational diabetes: does it exist?” Grand Rounds, University of Connecticut, January 2000. 243. “Gestational diabetes: does it exist?” and “Management of gestational diabetes.” Perinatal Update 2000, 16th Annual Conference of Memorial Health University Medical Center, Savannah Georgia, March 2000. 244. Postgraduate Course Director, Management of Medical Conditions In Pregnancy, American College of Obstetricians and Gynecologists 48th Annual Clinical Meeting in San Francisco, California, May 2000. 245. “Making the diagnosis of gestational diabetes” and “Management of gestational diabetes.” Gestational Diabetes: Putting the Pieces Together, sponsored by New Hampshire Dept of Health and Human Services, Manchester, New Hampshire, June 2000. 246. “Does gestational diabetes exist?” Grand Rounds at Long Island Jewish Medical Center, New Hyde Park, NY June 2000. 247. “The Manager’s role in enabling the Chair to be a successful leader.” Association of Managers of Gynecology and Obstetrics, Boston, September 2000.

Last updated 23 May 18 40

248. “Gestational diabetes: does it exist?” Yale University Endocrine Conference, New Haven, Connecticut, November 2000. 249. “Gestational Diabetes,” “Pre-Existing Diabetes,” “Corticosteroids to Enhance Fetal Maturity,” “Incompetent Cervix,” American College of Obstetricians and Gynecologists Course: Controversies in Obstetrics and Gynecology, New York City, December 2000. 250. “Managing cervical incompetence” and “What should we do about gestational diabetes?” Luncheon Conferences at American College of Obstetricians and Gynecologists 49th Annual Clinical Meeting, Chicago, April 2001. 251. “The HAPO Study.” Diabetic Pregnancy Study Group of North America, New York City, May 2001. 252. “Gestational diabetes: what’s the big deal?” George Mitchell Lecture, Tufts University School of Medicine, June 2001. 253. Moderator, Discussion Section on Pregnancy, American Diabetes Association 61st Annual Scientific Sessions, Philadelphia, June 2001. 254. “Corticoides perinatales,” “Medicamentos y embarazo,” “Incompetencia Cervical,” “Diagnóstico de la diabetes gestacional,” “Tratamiento de la diabetes complicada.” VI Congresso Latinoamericano de Perinatologia, Buenos Aires, Argentina, August 2001. 255. “Cervical cerclage,” “The use of maternal corticosteroids to prevent neonatal complications,” “Management of gestational diabetes,” and “Prescribing during pregnancy.” The 57th Obstetrical and Gynecological Assembly of Southern California, Los Angeles, February 2002. 256. “Gestational diabetes” Grand rounds at Mercy Hospital, Chicago, Illinois, April 2002. 257. “Screening and Diagnosis of Gestational Diabetes,” guest speaker at Resident Research Day, Mount Sinai Medical Center Department of Obstetrics and Gynecology, New York City, June 2002. 258. Moderator, Pregnancy Council Discussion Session, “GDM - How much is too much?” 62nd Scientific Sessions of the American Diabetes Association, San Francisco, June 2002. 259. “Management of pregnancy in women with pre-existing diabetes.” 33rd Annual Symposium on Diabetes, Connecticut Association of Diabetes Educators and American Diabetes Association,. Hartford, November 2002. 260. “Diagnosis and management of gestational diabetes.” McKenney Symposium of Kent Hospital, Warwick, RI, November 2002. 261. Moderator, Concurrent Session, Robert Wood Johnson Clinical Scholars Program Annual Meeting, Fort Lauderdale, FL, November 2002 262. Facilitator, session on “Preventing Burnout in Ob/Gyn Faculty,” Council of University Chairs in Ob/Gyn, Anaheim, CA, March 2003. 263. “Gestational Diabetes 2003" and “Prescribing During Pregnancy,” ACOG District I meeting in Rome and Taormina, Italy, September 2003. 264. “Prescribing in Pregnancy,” “Gestational Diabetes: Diagnosis and Management,” “Diabetes in Pregnancy: State of the Art 2004,” Annual meeting of Mississippi Section ACOG and the University of Mississippi Ob/Gyn Alumni, Jackson, Mississippi April 2004. 265. ”Current Management of Diabetic Pregnancy,” Current Issues Update at ACOG 52nd Annual Clinical Meeting, Philadelphia, May 1004. 266. “Management of Gestational Diabetes,” Luncheon Conference at ACOG 52nd Annual Clinical Meeting, Philadelphia, May 1004.

Last updated 23 May 18 41

267. “Gestational Diabetes: Update 2004,” Autumn in New York 2004: Tribute to John C. Hobbins, MD. New York, November 2004. 268. “Update on Gestational Diabetes,” “Prescribing During Pregnancy.” 25th Sunshine Seminar, University of Puerto Rico School of Medicine, San Juan, Puerto Rico, February 2005. 269. “Gestational Diabetes.” Internal Medicine Grand Rounds, St. Vincent’s Hospital, Manhattan, March 2005. 270. “Management of Complicated Pregestational Diabetes in Pregnancy,” “Update on Gestational Diabetes 2005,” “Cervical Insufficiency: Diagnosis and Management.” Azaleas, Dogwoods and Conditions Complicating Pregnancy. Medical University of South Carolina, Charleston, April 2005. 271. “Gestational Diabetes: Update for 2005.” John Rock Visiting Professor, Ob/Gyn Resident Research Day, University of Pennsylvania School of Medicine, Philadelphia, April 2005. 272. “Outpatient Management of Gestational Diabetes,” Management Issues in Genetics and Obstetrics for the Non-Subspecialist. Baystate Medical Center, Springfield, Massachusetts, April 2005. 273. Course Director, Series 060 Postgraduate Course "Contemporary Approach to Diabetes in Pregnancy." American College of Obstetricians and Gynecologists 53rd Annual Clinical Meeting, San Francisco, May 2005. 274. “Antidiabéticos orales en insulinorresistencia y diabetes gestacional,” “Hipoglucemia e hiperinsulinemias: efectos fetales,” “Prescripciones en el embarazo,” and “Complicaciones médicas de la diabetes en el embarazo.” XXIII Journedas de Obstetricia y Ginecología, Sociedad de Obstetrica y Ginecologia de Buenos Aires. Buenos Aires, Argentina, June 2005. 275. “Pharmacologic management of gestational diabetes: overview” 5th International Workshop-Conference on Gestational Diabetes. American Diabetes Association. Chicago, November 2005. 276. Chair, March of Dimes 2005 Prematurity Summit “A focus on prevention.” Providence, December 2005. 277. “Does cervical incompetence exist? What is the role of cerclage?” “Diagnosis and management of gestational diabetes,” “Use of oral hypoglycemic agents in obstetrics and gynecology,” “Drugs in pregnancy: which are safe and which are teratogenic?” Complications in Obstetrics. ACOG Postgraduate Course. New York City, December 2005. 278. Course Director, Series 060 Postgraduate Course "Contemporary Approach to Diabetes in Pregnancy." American College of Obstetricians and Gynecologists 54th Annual Clinical Meeting, Washington, DC, May 2006. 279. Discussant: “Ecker JL: Predicting gestational diabetes: choosing the optimal early serum marker.” American Gynecological and Obstetric Society Williamsburg, Virginia, September 2006. 280. “Management of pre-existing diabetes in pregnancy,” “Cervical insufficiency,” “The use of oral antidiabetic agents in Ob/Gyn.” Colorado Gynecological and Obstetrical Society Visiting Professor, University of Colorado, Denver, October 2006. 281. “The epidemic of gestational diabetes.” Autumn in New York 2006; Albert Einstein Medical Center, New York City November 2006. 282. Chair, March of Dimes Rhode Island Chapter 2006 Prematurity Summit Providence, November 2006. 283. “Research career development during and after residency.” APGO/CREOG Annual Meeting, Salt Lake City, March 2007. 284. Course Director, Series 060 Postgraduate Course "Contemporary Approach to Diabetes in Pregnancy." American College of Obstetricians and Gynecologists 55th Annual Clinical Meeting, San Francisco, CA, May 2007.

Last updated 23 May 18 42

285. “Diabetes in Pregnancy” and Workshop on “Oral Antidiabetic Agents in Pregnancy.” Native Women’s Health and MCH Conference. Indian Health Service. Albuquerque, New Mexico, August 2007. 286. “Gestational Diabetes: Diagnosis and Management 2007.” Northern New England Perinatal Quality Improvement Network Fall Conference. Woodstock, Vermont, November 2007. 287. Moderator, “HAPO Study Results.” Diabetes Special Interest Group, Society for Maternal-Fetal Medicine, Dallas, Texas, January 2008. 288. “Update on GDM: The HAPO Study Results and More.” 55th Annual Advanced Postgraduate Course of the American Diabetes Association. San Francisco, February 2008. 289. “HAPO Study: Potential glycemic thresholds.” International Workshop-Conference on Gestational Diabetes, IADSP (International Association of Study Groups on Diabetic Pregnancy) Pasadena, CA, June 2008. 290. “Update on Gestational Diabetes.” District II ACOG Summer Meeting, Verona NY, July 2008. 291. “Update on the Diagnosis of Gestational Diabetes.” American Association of Clinical Chemists Annual Meeting, Washington, DC, July 2008. 292. “GDM: New diagnostic cutpoints? New treatment strategies?” American Diabetes Association 56th Annual Advanced Postgraduate Course. New York, NY, February 2009. 293. Chairperson, Plenary Session “HAPO (Diagnosis) and NIH (Intervention) Studies – Towards a Consensus.” 5th International Symposium on Diabetes and Pregnancy. Sorrento, Italy, March 2009 294. “Gestational Diabetes: What’s New?” Massachusetts General Hospital Vincent ObGyn Grand Rounds, Boston, April 2009. 295. “Controversies in Gestational Diabetes.” Yale Obstetrical and Gynecological Society, New Haven, April 2009. 296. Clinical Seminar: “Contemporary Approaches to Diabetes in Pregnancy.” Course Director. American College of Obstetricians and Gynecologists 57th Annual Clinical Meeting, Chicago, May 2009. 297. Can We Use the HAPO Study as the Basis for Change? 11th Annual Meeting of the Diabetes in Pregnancy Study Group of North America, Baltimore, May 2009. 298. Toward New Criteria for Gestational Diabetes. American Gynecologic and Obstetrical Society, Chicago, October 2009. 299. HAPO Update. 9th World Congress of Perinatal Medicine. Berlin, Germany, October 2009. 300. Gestational Diabetes Update – 2009. New England Obstetrical and Gynecological Society Fall Meeting, Sturbridge MA, November 2009. 301. “The independent contribution of BMI to outcomes in the HAPO study.” GDM Pasadena II: An International Conference on Gestational Diabetes. Pasadena, CA April 2010. (Coustan DR, Metzger BE, Lowe LP, Dyer AE); also moderator of session on pharmacologic management of GDM. 302. Clinical Seminar: “Contemporary Approaches to Diabetes in Pregnancy.” American College of Obstetricians and Gynecologists 58th Annual Clinical Meeting, San Francisco, May 2010. 303. The evolution of perinatal care: a personal perspective. Sloane Academic Assembly of graduating residents and fellows, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York City, June 2010. 304. Developing new criteria for gestational diabetes. Rosen Lecture, Sloane Symposium, , Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York City, June 2010.

Last updated 23 May 18 43

305. Diabetes: Clinical research experiences in enrolling pregnant women with chronic diseases. Office of Research in Women’s Health Research Forum: Issues in Clinical Research; Enrolling Pregnant Women. Bethesda, NIH Clinical Center, October 2010. 306. New recommendations for diagnosing gestational diabetes, Use of oral antidiabetic drugs in pregnancy, and Management of complicated diabetes in pregnancy. 36th Annual High Risk Obstetrics Seminar, Vanderbilt University Medical Center, December 2010. 307. From the O'Sullivan Criteria to the New Diagnostic Criteria, and HAPO Results That Support the IADPSG Recommendations. 6th International Symposium on Diabetes & Pregnancy, Salzburg Austria, March 2011. 308. Clinical Seminar: “Contemporary Approaches to Diabetes in Pregnancy.” American College of Obstetricians and Gynecologists 59th Annual Clinical Meeting, Washington DC, May 2011. 309. New Criteria for Gestational Diabetes. Rhode Island Diabetes Council, RI Department of Health, May 2011. 310. Management of Diabetes in Pregnancy, Labor and Delivery. Neil J. Grey, MD Lecture in Diabetes. Hartford Hospital, Hartford CT, May 2011. 311. New International Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. American Association for Clinical Chemistry. Atlanta, Georgia, July 2011. 312. Nuevos Criterios Para Diabetes Gestacional ¿se Deben Adoptar Los Cambios? VII Curso Internacional “Medicina Materno Fetal.” Mexico City, Mexico, September 2011. 313. Gestational Diabetes Update: Diagnosis and Management in 2011. The David Jacobwitz MD Memorial Obstetric Quality and Safety Conference. Atlantic Health System, Morristown NJ. October 2011. 314. Diagnosis and Management of Diabetes During Pregnancy. 3rd Annual Meeting of New England Region, American Association of Clinical Endocrinologists. Sturbridge, MA October 2011. 315. Hot Topics in Pregnancy. American Diabetes Association 59th Annual Postgraduate Course. San Francisco, February 2012. 316. The O’Sullivan Criteria: Where Did They Come From? American Diabetes Association 72nd Annual Scientific Sessions, Philadelphia, June 1012. 317. Coustan DR: We should use the American Diabetes Association (ADA) recommendations for the diagnosis of hyperglycemia in pregnancy. American Association for Clinical Chemistry Debate on the Diagnosis of Gestational Diabetes. Los Angeles, CA 17 July 2012. 318. Coustan DR: Update on gestational diabetes: 2012. Grand Rounds, Sponsored by March of Dimes San Antonio Chapter, Department of ObGyn, University of Texas Health Sciences Center at San Antonio, San Antonio Texas, October 2012. 319. Coustan DR: Update on gestational diabetes: 2012. Grand Rounds, Sponsored by March of Dimes San Antonio Chapter, Department of ObGyn, San Antonio Military Medical Center, San Antonio Texas, October 2012. 320. Coustan DR: Diagnosis and management of gestational diabetes. Emirates Diabetes and Endocrine Congress. Dubai, United Arab Emirates, October 2012. 321. Coustan DR: Historical and future perspectives of new guidelines in GDM: would it change materno-fetal outcomes? The Second Global Diabetes Summit. The Ohio State University, Columbus Ohio, November 2012. 322. Coustan DR: Diabetes in pregnancy. 11th Annual Symposium on Advanced Diabetes Management for Endocrine Fellows. American Association of Clinical Endocrinologists. Dallas, TX November 2012. Last updated 23 May 18 44

323. Coustan DR: Current diagnostic methods and thresholds of gestational diabetes. NIH Consensus Development Conference: Diagnosing Gestational Diabetes. Bethesda, MD, March 2013. 324. Coustan DR: Moderator, “Changing a Health Care Policy – Towards a Consensus of Consensuses” and “New Frontiers in Prediction and Prevention of Preeclampsia.” 7th International DIP Symposium: Diabetes, Hypertension, Metabolic Syndrome & Pregnancy. Florence, Italy, March 2013. 325. Coustan DR: Criteria for the diagnosis of gestational diabetes and its implications: news from March 2013. Sixth Annual Alumni Reunion of the Yale Obstetrical and Gynecological Society honoring Roberto Romero, MD, DMedSci, New Haven CT, April 2013. 326. Coustan DR: “Gestational diabetes: do we need new diagnostic criteria?” and “Management of gestational diabetes in 2013.” Fifth Annual Philadelphia Prenatal Diagnosis and Obstetrics Conference. Philadelphia PA, June 2013. 327. Coustan DR: “Update on Gestational Diabetes 2014.” Missouri/Arkansas/Kansas/Oklahoma ACOG Combined Section Meeting, Ridgedale Missouri, June 2013. 328. Coustan DR: “Tratamiento de pacientes con diabetes gestacional” and “Hiperglucemia y resultados adversos del embarazo en el studio HAPO: ? Podemos utilizar los resultados como base para el cambio” 4th Congresso Nacional de Medicina Perinatal. Mexico City, Mexico, August 2013. 329. Coustan DR: “Diagnosis of GDM: reinvigorating the debate -where do we go from here?” Diabetes in Pregnancy Study Group of North America, Washington DC, November 2013. 330. Coustan DR:” New diagnostic criteria.” World Diabetes Congress, International Diabetes Federation, Melbourne Australia, December 2013. 331. Coustan DR: “The HAPO study and the development of IADPSG criteria for GDM.” Diabetes & Pregnancy, Postgraduate Course at 34th Annual Meeting of Society for Maternal-Fetal Medicine. New Orleans, February 2014. 332. Coustan DR: Diagnosis of gestational diabetes. 14th Bergmeyer Conference: Women's Health. International Federation of Clinical Chemistry and Laboratory Medicine. Grainau, Germany, March 2014. 333. Coustan DR: “Do we need new criteria for gestational diabetes?” Bernard Pimstone Memorial Lecture. Society for Endocrinology, Metabolism and Diabetes of South Africa, Durban South Africa, April 2014. 334. Coustan DR: “Diabetes in pregnancy.” WPU Jackson Memorial Lecture. Society for Endocrinology, Metabolism and Diabetes of South Africa, Durban South Africa, April 2014. 335. Coustan DR: What can ObGyns do about the obesity epidemic?” Presidential Address, 33rd Annual Meeting of the American Gynecological and Obstetrical Society. Chicago, Sept 2014. 336. Coustan DR: What can ObGyns do about the obesity epidemic?” 14th Annual Perinatal Center Conference, MetroHealth Medical Center, Cleveland, Ohio, October 2014. 337. Coustan DR: Do we need new diagnostic criteria for gestational diabetes?” ObGyn Grand Rounds, Bridgeport Hospital, Bridgeport CT, October 2014. 338. Coustan DR and Metzger BE: “Meet the Experts: Pro and con for IADPSG criteria for GDM” DIP 2015, 8th International Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy, Berlin, Germany, April 2015.

339. Coustan DR. Grand Rounds Lecture. Women and Infants’ Hospital. “DKA and Other Complications of Diabetes in Pregnancy.” Providence, RI. May 14, 2015.

340. Coustan DR. Visiting Professor, Resident and Fellow Research Day. “Controversies in Gestational Diabetes” and “How Should Ob/Gyns Respond to the Epidemic of Diabesity.” Madigan Army Medical Center, Tacoma, WA. May 27, 2015. Last updated 23 May 18 45

341. Coustan DR. Madras Diabetes Research Foundation Gold Medal Oration: “Gestational diabetes mellitus: The need for international consensus.” International Update on Gestational Diabetes Mellitus. Chennai, India, September 2015. 342. Coustan DR. Visiting Professor, Department of Medical Endocrinology. “Diagnosis and Management of Gestational Diabetes.” University of Louisville. Louisville, KY. November 18, 2015. 343. Coustan DR. “ Diagnosing gestational diabetes: how did we get to where we are?” Diabetes Scientific Forum of the Society for Maternal Fetal Medicine Annual Meeting, Atlanta February 2016. 344. Coustan DR. “Management of gestational diabetes.” The Third International Diabetes Forum of Shijiazhuang, Shijiazhuang, People’s Republic of China, May 2016. 345. Coustan DR: “Management of gestational diabetes.” Diabetes Center of People’s Liberation Army, 306th Hospital of PLA, Beijing, People’s Republic of China, May 2016. 346. Coustan DR: Moderator, Public Health Issues. Audit meeting of the Diabetic Pregnancy Study Group of the European Association for the Study of Diabetes. Dublin Ireland, September 2016. 347. Coustan DR: “Do we need new criteria for gestational diabetes” and “Management of preexisting diabetes in pregnancy.” Fourth Annual Diabetes Symposium, Baptist Hospital of Miami, October 2016. 348. Coustan DR: “Do we need new criteria for gestational diabetes?” W. Tabb Moore Visiting Professor in Endocrinology, Johns Hopkins University, Baltimore MD February 2017. 349. Coustan DR: “Management of gestational diabetes.” Maryland Endocrine Society, Baltimore MD, February 2017. 350. Coustan DR: “Why do we need new diagnostic criteria for gestational diabetes?” Northwestern University Endocrinology Seminars, Chicago, May 2017. 351. Coustan DR: “Do we need new criteria for gestational diabetes?” Perinatal Diabetes: Opportunities for Prevention and Care. Sweet Success Express NYC, October 2018. 352. Coustan DR: “Pros and cons with non-insulin therapies in gestational diabetes.” Clinical Endocrinology Update, Endocrine Society, Anaheim California, October 2018. 353. Coustan DR: “Management of comorbidities for pregnancies complicated by pre-existing diabetes mellitus” and “Professional organization recommendations and medication management for gestational diabetes mellitus.” 22nd National Research Conference Diabetes and Pregnancy: Prevention – Return on Investment, Sweet Success Express, Anaheim CA November 2018.

Last updated 23 May 18 46